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 In the ancient period Indian saints handled the plants and herbs for long life with better 
health and lived more than thousand years of age. The sages were called Rishis in the North and 
Siddhars were known as Ayurveda and Siddha. 
According to Siddha predictions,  it is known to the world that Lord Siva taught the 
Siddha principles and philosophies to Matha,  Sri Parasakthi. After that the Siddha principles 
were presented to the followers of Lord Siva sakthi,  to Siddhars,  starting with siddhar- 
Nantheesar,  then to Siddhar Thirumoolar,  Agathiyar and other disciples along with the 18 
Siddhars and so on.  
In general,  single and even compound medicines are advised for the patients by knowing 
the pulse diagnosis methods,  the variations of Naadi in their hands by means of vali,  Azhal,  
Iyyam,  or in other words called Vaatham,  pitham and kapam,  respectively.  
Siddhars classified the disease in different topics and accounted the total diseases for 
human body as 4448 diseases. They mentioned about the curable and incurable disease along 
with the symptoms of the body and predicated the concerned,  proper medicines also.  
Everybody can follow Siddha system of medicine even for the whole family and even for 
the entire earth in all circumstances. Siddha system of science is an everlasting principle to the 
world. Siddha system presents the slogan,  “Food is being medicine and medicine is being 
food” to people.  
   Amla has been regarded as a sacred tree in India. The tree has worshipped as mother 
earth and is believed to nurture humankind because the fruits are very nourishing.  
Amla is satvic i.e. stimulates spiritual purity. Amla increases OJAS (the subtle essence of living 
matter,  the foundation of good health,  mental sanity and spiritual growth).  
 According to Siddha literature Peenism noi is a condition due to the  vitiated azhal humor 
.As per mentioned in the mooligai text that Nelli has pulippu, thuvarppu, and inippu suvai  
     ‘hqk<k!lkqgiqh<hqe<!OhSl<!hiqgivl<!
! ! ! Sk<kk<!KuOviM!osiz<zqeqh<Hs<!.!sk<kiGl<!
! ! ! jgh<Hs<!SjuOb!gVkuke<!uQX!
! ! ! wb<h<hjmB!ole<Xjvk<ki!iqr<G”.!
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As per the above text thuvarppu, and inippu suvai neutralize the azhal humor . 
“ofz<zqg<gib<g<!Gh<hqk<kl<!fQr<G!lke<Htqh<hiz<!
! ! ! osz<ZOl!uiklkqx<!OsIKuviz<!.!osiz<Zjlbl<!
! ! ! YMlqjks<!sqk<kk<kqz<!de<e!neZmOe!
! ! ! %Mhqx!OlgLl<!Ohir<!%X”.)Ok/G*!
The above text also proves it 
In that way,  the author has selected “Nelli Vatral Chooranam” as a dissertation topic for 
management of “Peenism” (Sinusitis) 
The author wishes to dedicate this work to the holy Siddhar. 
fz;Nld; fky kyu;ghjk; fhz;lYNk  
      tpz;Nl nahope;jd tpidah apdhty;yhk; 
                         njhz;Nl nra; njd;Wk; njhOJ topnahOf  
























AIM AND OBJECTIVES 
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The aim of the dissertation is to evaluate the efficacy of Nellivatral Chooranam 
(Emblica officinalis) in the management of Peenism in accordance with the reference made in 




  To main objective of the present study is to highlight the efficacy of the drug through the 
following  
 
 Collection of evidences in siddha aspects.  
 
 Collection of evidences in botanical aspects. 
 
 Bio- Chemical analysis.  
 
 Physical Properties. 
 
 Quantitative analysis 
 
 Toxicological study. 
 
 Pharmacological studies. 
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ofz<zq!
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KuIh<hq!!  - Astringent!
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! H,!!!!! ! !
GtqIs<sqB{<mig<gq!! -     Refrigerant  
! ! lzlqtg<gq!! ! .!!Laxative!
! hpl<!!! ! ! !
GtqIs<sqB{<mig<gq! -   Refrigerant!
! ! sqXfQIh<ohVg<gq!! .!!Diuretic 
lzlqtg<gq!! ! .!!Laxative!
G{l<!
ofz<zqg<gijbh<! hgx<OhiK{<{qz<?! ouxq?! JbOfib<?! hQfqsl<?! uib<fQIs<Svh<H?!
uif<kq?! lbg<gl<?! kjzs<Spzz<?! lzhf<kl<?! hqvOlgl<!-ju!Ohil</! !gile<! Ohie<x!
npG{<miGl</!!nke<!Htqh<hiz<!KuIh<hiz<!JbLl<!fQr<Gl</!
! ! ! ! “hqk<kle!jzbl<!hQfsl<uib<!fQI!uif<kq!
! ! ! ! lk<klzg<!giMl<!lbg<gLlqz<!.!yk<kUV!
! !!!!! ! ! uqz<zqg<gi!bl<lVr<gi!ole<eim<gi!zf<OkIf<Ok!
! ! ! ! ofz<zqgi!bl<lVf<!K{Q”!
! ! ! ! “ofz<zqg<gib<g<!Gh<hqk<kl<!fQr<G!lke<Htqh<hiz<!
! ! ! ! osz<ZOl!uiklkqx<!OsIKuviz<!.!osiz<Zjlbl<!
! ! ! ! YMlqjks<!sqk<kk<kqz<!de<e!neZmOe!






! ! ! ! bqz<zi!lzglqVg<GOl!.!-!z<zilz’! !
! ! ! ! uijpg<!geqBl<!ujmB!lqPK!L{<hie<!
! ! ! ! uijpg<!geqBt<!juk<k!ue<”- )Ok/b/ou* 
ofz<zqlvk<kqe<!OuI?!uqjv?!hm<jm?!=Ig<G?!gib<?!geq?!ux<xz<!-!jugjt!
gx<h! Ljxh<hc! DXgib<?! Kjubz<?! GcfQI! osb<K?! kg<g! hk<kqbk<Kme<!





fiUg<Gs<! Sjujbk<! kVgqe<x! ofz<zqLt<tqbiz<! dm<S,M?! GVkqbpz<! Ofib<?!














&! h<hjmf<kuVl<! -! tjlBjmb! lih<hqt<jtjbh<Ohiz<! npGme<! -!
Vg<gOu{<ce<?!ofz<zqg<geqjb!higR<!osb<K!d{<[kz<!Ou{<Ml</!
hbe<gt<!
 ofz<zqg<gijbk<! Kjubz<! osb<K! sih<hqm?! Sjubqe<jl?! uif<kq! -! jugjth<!
Ohig<Gl</!
 ofz<zqux<xjzg<!GcfQI!osb<K!ogiMg<g?!lbg<gl<?!kigl<?!Yg<gitl<!-!ju!fQr<Gl</!
 , iyf; nfhOe;ij miuj;J Nkhhpy; fye;J rPjf;fopr;rYf;Ff; nfhLf;fyhk;.  
ney;yp tw;wiyf; (FbePH) nra;J rPdp $l;bg; ghy; NrHj;Jr; rhg;gpl 
R+L;>Mz;Fwpg;Gz;> the;jp jPUk;. 
ney;yp tw;wy; Rj;jp32 
!!! hSl<!hizqz<!nuqk<K!ogim<jm!fQg<gq!dzIk<kUl<!
ofz<zqg<gib<k<!jkzl<<!
ofz<zqh<hps<siX?! ohie<eir<gi{qs<siX?! gx<xijps<siX?! sqXgQjvs<siX?! Nuqe<hiz<!
-!jugt<!ujgg<G!3911!lq/zq/?!osu<uqtfQI! 22?311!lq/zq/?!wt<ot{<o{b<! 5311!lq/zq!-!
jugTl<?! nkqlKvl<?! Ogim<ml<?! Wzl<?! GOvisi{q?! hs<sqjz?! H,zi?! gk<K~iq! lR<st<?!
sikqg<gib<?! sikqh<hk<kqiq?! kqiqgMG?! kqiqhjz?! -! zur<gh<hk<kqiq?! -! zur<gh<hm<jm?!
H,R<sif<K?! Osil<H?! uiz<! lqtG! -! jugt<! ujgg<Gg<! gpR<S.4)26/4gq*! wMk<K! Nuqe<!
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hizqz<!njvk<K!Olx<hc!six<jx!w{<o{Bme<!gzf<K!sqX!kQbqz<!wiqk<K!uck<Kk<!kjz!
&! p<sq! uv! g{<! ljxU?! lijzg<g{<?! g{<Ofib<! :7?! oum<jm?! jggiz<! gif<kz<?! npz<!
Gx<xk<kiz<!d{<mil<!Ofib<gt<?!dml<ohiqU!-!jugt<!fQr<Gl</!
ofz<zqLt<tq!-!Ozgqbl<!
ofz<zq!Lt<tq! 811!gqvil<?! 55911!lq/zq! )56!zqm<mI*!Nx<X!fQIuqm<Mg<! gib<s<sq! 6711!
lq/zq!ux<x!juk<K!uck<okMk<K?!sIg<gjv!966!gqvil<!Ohim<M!hiGhkl<!uVl<!kV{k<kqz<?!
nkqlKvl<?! %jgfQX?! kqvim<js! ujgg<G! 79! gqvil<?! kqh<hqzq?! OhiQs<sr<gib<! ujgg<G! 213!
gqvil<! -! jugjt! olz<zqbkib<h! ohick<K! nkqzqm<M! 811! lq/zq/! Oke<uqm<Mg<! gqtxq!
wMk<K?! He<jeg<gib<! ntU! gijz?! lijz! -! VOujtBl<! -! VhK! fit<! sih<hqm<Muv!
gilijz?! hi{<M?! npx<sq?! kqlqIuiB?! Osijg?! fQIs<SVg<G?! Ge<ll<?! dml<ohiqU! fQr<Gl</!!
Hjg?!dh<H!-!jugjt!fQg<gUl</!!
ofz<zqLt<tqbqe<!GcfQI!
! ! ! ! “hiiqjsf<k!ofz<zqLt<tq!h{<hie!%uqjtBR<!
! ! ! sQiqjsf<k!sQvgLR<!OsIf<kSg<Gl<!.Ouiqjsf<k!
! ! ! sqk<kiLm<c!ofx<ohiiqBR<!OsIk<Kg<!gqbiplqcz<!
! ! ! hqk<ksk<kq!uqm<Mh<Ohil<!OhS/”!
ofz<zqLt<tq?!uqz<ul<?!sQvgl<?!Sg<G?!sqx<xiLm<c!OuI?!ofx<ohiiq!-!jugjt!ye<X!
%m<cg<!GcfQI!osb<K!hVgqz<!hqk<k!sk<kq!fQr<gqh<Ohil<?!
!! ! ! ofz<zqg<gib<!OsVl<!hQeqsk<kqx<gie!lVf<Kgt<!
2/utq?!npz<?!Jbl<?!fQI?!GVkq?!sQp<?!sqvib<!&!g<G!Ofib<gm<Gk<!jkzl<36!
jgbif<kgjv?! Noki{<jm?! sUiqh<hpl<?! oux<xqjz?! ofz<zqg<gib<?! wZlqs<sl<hpl<?!
fivk<kl<hpl<?!LSLSg<jg?!Lmg<gx<xie<!-!jugtqe<!siX!ujgg<Gh<!hc!¼ (½ zqm<mI*!
wt<ofb<! hc! )2 zqm<mI*! ye<xigg<! gzf<K! nkqz<! lqtG! hzl<! ¼(8.75 gqvil<*?! /nkqlKvl<?!
s{<hgh<h,?!sQvgl<?!uqmr<gl<?!dVtiqsq?!Okijg!uqtr<Gl<!npx<gib<?!gk<K~iqlR<st<?!Wzl<?!
gqvil<H?! kitqshk<kqiq?! gVuih<hm<jm! ujgg<G! uvigoejm6)32gqvil<*?! OgiOvisje!
uvigoejm! 4)23//7gqvil<*! -! ux<jxh<! ohick<Kh<! Ohim<Mg<! gib<s<sq! uck<K! &! e<X!
fim<ogiV! Ljx! &! p<Guke<xqBl<?! lqtjgg<! ogim<jmh<hig<gtU! oux<xqjzs<siX!




! ! ! ! KtsqBr<!ogit<otiM!osuqbf<!
! ! Kb<b!uz<zijv!bgk<kqBl<!ofis<sqz<!
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! ! ! osix<xPkijt!Lt<tr<gq!
! ! ! le<E!sQvgLl<!Hr<gkqe<!uqk<Kl<!











kitqshk<kqiq?! Ktsq?! ogit<T?! osu<uqbl<?! uz<zijv?! ngk<kq?! ofis<sq?! kPkijp? 
Lt<tr<gq?! sQvgl<?! Hr<gl<! uqk<K?! giqsijz?! uib<uqmr<gl<?! ogicOuzq?! kqh<hqzq! &! zl<?!
lR<st<?!Gg<gqz<?!gMG?!Okukivl<?!dt<tq?!lqtG?!-!zur<gl<?!fiBVuq?!gVR<sQvgl<?!Sg<G?!
kqh<hqzq?! kie<xq?! ofz<zqux<xz<?! gMg<gib<! -!jugotz<zil<! fisqBZ{<mil<! Ofib<gTg<G!
Wx<x!lVf<Kgoteg<!%xqBt<tiI/!
!
4/!! nXGOui<37!ofz<zqg<gib<?! ohie<eir<gi{q?! sqXgQjv?!kijpuqPK!-!ux<xqe<! siX/!




sQf<kqz<! ogic?! sqx<xiLm<cOui<?! ujgg<G! 21hzl<! )461gq/*!-!jugjt!-!ck<K! 5!
lvg<giz<! k{<{Qiqz<! Ohim<M! GX{qbib<g<! gib<s<sq! uck<K?!nkqz<! fz<oz{<o{b<! hSuqe<!
hiz<! ujgg<G! 2hc)3zqm<mI*! gzf<K! kqiqgMG?! kqiqhjz! )gMg<gib<?! ofz<zqg<gib<?!
kie<xqg<gib<*?!nkqlKvl<?!Ogim<ml<?!Wzl<?!se<ezur<ghm<jm?!s{<hgh<h,?!sqx<xvk<jk?!oum<c!
Oui<?! uqzilqs<sl<! Oui<?! skGh<jh?! smiliR<sqz<?! lvlR<st<?! lR<sqm<c! Okuivl<?! ngqz<?!















ofz<zqux<xz<?! liKjt?! uqti?! gti?! Le<je?! kgjv?! gijv?! $jv?! He<je?!
k{g<G! Ngqb! -u<Oui<gjtobz<zil<! yV! fqjxbib<! wMk<Kg<! GcfQvig<gqbkqz<! Sg<G?!
lqtG?! kqh<hqzq?! -zur<gl<?! nkqlKvl<! Ngqbjugjts<! sleig! wMk<K! out<tim<M!











14. Vyhjpr; R+uzk;22 
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EMBLICA OFFICINALIS Linn 
BOTANICAL ASPECT 
 According to Benthem & Hooker classification. 
 Kingdom   - Plantae 
 Division    - Angiosperma 
 Class     - Dicotyledonae 
 Subclass    - Monochlamydeae 
 Series    - Unisexuales 
 Family    - Euphorbiaceae 
 Genus    - Emblica 
 Species   - officinalis 
VERNACULAR NAME 11, 36, 40 
            Tamil    - Nelli 
            Eng    - Indian Goosberry 
 Hindi    - Amlika,  Amvala 
 Kanada   - Nellka 
 Malayalam   - Nellimaram 
 Sans    - Amalaki 
            Tel    - Usirikaya  
 Beng    - Amlaki 
 Ceylon    - Toppinelli 
 Persian   - Amelah 
OCCURRENCE & DISTRIBUTION36, 38 
Throughout India,  in deciduous forests and on hill slopes upto zoom,  and also in 
Ceylon,  China and Malay island. 
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DESCRIPTION  
A deciduous small or middle sized tree, with crooked trunk and spreading branches. 
BARK 
Greenish grey,  peeling off in conchoidal flakes, branchlets glabrous or finely pubescent,  
10-20cm,  long,  often deciduous. 
LEAVES 
Subsessile 10-13 by 2.5-3mm closely set along the branchlets,  distichous,  light green,  
glabrous ,  narrowly linear,  obtuse,  imbricate,  when young having the appearance of pinnate,  
leaves,  stipules ovate,  finely acute. 
FLOWERS 
Greenish yellow in axillary fascicles on the leaf- bearing branchelts,  often on the naked 
portion below the leaves with  fimbriate bracts at the base. 
MALE FLOWERS 
Numerous,  on short slender pedicles. Sepals 6,  oblong,  obtuse,  12mm long. Disk 0 . 
Anthers 3 on a short central column. 
FEMALE FLOWERS 
Few  suppressible  sepals as in the male Disk a lacerate cup,  ovary 3- called styles 
connate at the base,  irregularly twice –2 fid with acute lobes. 
FRUIT 
1.3-1.6cm diam. Fleshy globose with 6 obsure vertical furrows,  pale yellow of there 2- 
seeded crustaceous cocci 
SEEDS 
6, 3 –gonous 
PARTS USED39, 40, 42 
 Fresh fruit  
 Dried fruit  
 The nut or seed 
 Root 
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 Bark and Flowers 
 Ripe fruits used generally fresh,  dry also used.  
CHEMICAL CONSTITUENTS38, 40, 41, 43, 58, 61 
The Major chemical constituent of amla are  
1.Phyllembin  
2.Ascorbic acid (vitamin C)  




7.Tannins and  
8.Pectin   
The  minor constituents are alkaloids phyllantidine and phyllantine,  minerals,  Carotene,  
nicotinic acid,  riboflavin,  D-glucose,  D-fructose,  myoinositol and pectin with D-galacturonic 
acid,  D-arabinosyl,  D-galactosyl,  D-xylosyl,  L-rhamnosyl and D-glucosyl residues,  embicol,  
mucic,  indole acetic acid and four other auxins - a1, a3, a4 and a5 two growth inhibitors R1&R2 
phyllembim.Lupeol, oleandic aldehyde and O-acetyl oleanolic acid, poly phenolic compounds 1, 
2, 3, 6-trigalloyl glucose,  terchebin and corialgin. 
 
STRUCTURE OF  PHYLLEMBIN61   STRUCTURE OF  VITAMIN C61  
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CHEMICAL COMPOSITION OF THE FRUIT 40, 44 
The fruit pulp which constitutes 90.97 percent of the whole fruit contains 70.5 percent 
moisture. The total soluble solids constitute 23.8 percent of the juice. The acidity of aonla is 3.28 
percent on pulp basis. The pulp contains 5.09 percent total sugars and 5.08 percent reducing 
sugars. The ascorbic acid content is 1, 094.53mg per 100ml of juice. The tannins and pectin 
content of the pulp is 2.73 percent and 0.59 percent respectively. The fruit pulp contains 0.75 
percent protein. The mineral content of the edible portion,  as represented by its ash,  is 2.922 
percent. The percentage content of the mineral elements,  viz phosphorus,  potassium,  calcium,  
magnesium,  and iron is 0.027,  0.368,  0.059,  0.248 and 0.004 respectively.  
PHARMACOLOGICAL ACTIVITIES40,  42,  44,  61 
The fruit pulp of Emblica officinalis is one of the important drugs used in the Indian 
systems of medicine. It is used both as a medicine for some diseases and as a tonic to build up 
lost vitality and vigors. 
The active principle appeared to be present in a fairly concentrated form in a fraction 
which was prepared by treating 80%  alcoholic extract of myrobalans with HCl and extracting 
with other. This semi-pure fraction inhibited the growth of micrococcus pyrogens var. aureus,  
salmonella,  typhosa and paratyphi at a concentration of 0.21mg/ml and that of M.pyrogens 
var.albus S.schottmulleri and S.dysentrics at a concentration of 0.42mg/ml when tested by agar 
steak method. 
During general pharmacological screening of the 80%  alcoholic extract of myrobalans 
for various,  pharmacodynamic actions,  a cardiotonic activity was observed. This property did 
not appear to be a true cardiotonic activity but was more like the actions of adrenaline.  
The plant gave the tannins glucogellin corilagin,  cheoulagic acid and 3, 6- 
digalloylglucose. The fruit contained vitamin C L-(+)-  thio ascorbic acid,  cytokinin,  substances 
identified as zeation riboside and nucleotide suspension culture gave phyllembin. 
The root yield ellagic acid,  quercetin and beta –sitosterol. Alcoholic extract of the plant 
(1g/kg) has shown an increase in the cardiac glycogen and decrease in SGOT,  SGPT and LDH 
in isoprotenol treated rats,  suggesting a cardio protective action.  
According to Database on medicinal plants it has following actions spasmolytic ,  mild 
CNS depressant,  hypolipidaemic,  anti-atherosclerotic,  anti-mutagenic,  anti-microbial,  anti-
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oxidant,  immunomodulatory,  anti-fungal,  anti-tumour,  hypoglycemic,  anti-inflammatory,  
anti-bacterial,  anti-ulcer,  adrenergic potentiating and HIV-1 reverse transcriptase inhibitory 
action.  
The antiscorbutic value can be conserved by preserving the fruit in salt solution or in the 
from of dry powder.  
USES38,  61 
 Amla juice has twenty to thirty times more vitamin C than orange juice. Daily 
requirement of vitamin C is 90-150 mg per day. 100ml of Amla juice contains c between 
650 to 950 mg whereas 100gm oranges contain 30mg vitamin c. That means 20 to 30ml 
of Amla juice is sufficient to prevent and treat various ailments and fight various 
illnesses.  
 The edible fruit tissue of Amla contains protein concentration 3 fold and ascorbic acid 
concentration 160-fold than those of apples. This fruit also contains considerably higher 
concentration of most minerals and amino acids than apples.  
 Amla is most useful treatment of ulcers and hyperacidity.  
 Amla builds immune system to fight against all kind of viruses like of Hepatitis,  AIDS,  
Influenza and many others.  
 Amla also reduces unwanted fat and also significantly reduces the levels of free fatty 
acids. In addition Amla in a raw or natural form reduces cholesterol and cholesterol 
induced atherosclerosis (Obstruction of the arteries),  making it a useful natural product 
to fight obesity,  cholesterol and heart diseases. Amla has exhibited considerable effect in 
inhibiting the HIV virus and very useful in enhancing the immunity.  
 A potent antioxidant,  hypolipidemic,  antibacterial,  antiviral antacid and digestive aid. 
 Regulates blood sugar and prevents liquid peroxidation in cell membranes.  
 Useful in eye problems especially in inflammations. Having been shown to improve 
nearsightedness significantly in recent studies,  amla is the most frequently used cataract 
medicine. Amla is a potent inhibitor of free radicals,  which are one cause of cataracts.  
 Prevent premature greying of hair and makes them strong & free dandruff.   





Amla Juice-20 to 30ml per day.  
CLASSICAL USE 39, 37, 40  
Fruit 
         Cooling , Carminative ,  Alternative , Laxative , Tonic, Antipyretic. 
 Useful in burning sensations,  vomiting,  biliousness,  Urinary discharge,  thirst,  
leprosy,  constipation  inflammations,  erysipelas,  piles and  anaemia.    
 Fruit  is useful in the diseases of the heart,  liver complaint,  cold in  the nose,  stops 
nasal haemorrhage.  
 The unripe fruit is cooling,  diuretic,  and  laxative. The exudation from the incisions 
on the fruit is used as an external application in inflammation of the eye.  
 Juice or extract of the fruit with honey and pipli added is given to stop hiccup and in 
painful respiration.  
 Dried fruit immersed in water in a new earthern vessel a whole night yields a 
decoction which is used as a collyrium in ophthalmia.  
 Dried fruit is useful in haemorrhage,  diarrhoea and dysentery. 
 With iron it is a valuable remedy in anemia,  jaundice and dyspepsia. 
 A sarbath prepared from the fresh fruit with or without raisins and honey is a 
favourite,  cooling drink which has a diuretic effect. 
 A decoction of the leaves is also useful as a mouth wash in aphthae.     
Leaf 
 The leaf is used in ophthalmic,  and incipient blindness. 
 In Cambodia ,  the leaves are used in the preparation of antithermic  lotions and baths.  
 In Baroda,  the leaves are used as an infusion with fenugreek seeds in cases of chronic 
dysentery,  and are also considered a bitter tonic.   
Bark 
 The root,  bark and the ripe fruit are astringent. The flowers are refrigerant and aperient. 
 In the Konkan,  the juice of the fresh bark with honey and turmeric is given in gonorrhoea.  
Flowers  






















MATERIALS AND METHODS 
COLLECTION OF DRUG 
The fresh fruits are collected from the surroundings of Salem. Authentication of plant 
from the Botanist,  National Institute of siddha,  Tambaram sanatorium. 
PREPARATION OF THE MEDICINE 
 Fruits are cut into small pieces. 
 Dried in sunlight. 
 Making into fine powder by pulverizer. 
 Process of Ultra filtration (vasthiragayam) was done. 
STORAGE OF CHOORNAM 
The fine powder was stored in a clean and dry air tight container. sLife span of choornam 
is 3 months from the date of preparation. It was used within that period. 
DOSE   
1-2gm twice daily,  before meals 
VEHICLE  
 Honey.   
ROUTE OF ADMINISTRATION 






 MATERIALS AND METHODS 
PREPARATION OF DRUG 
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 CHEMICAL ANALYSIS OF NELLIVATRAL CHOORANAM 
SI 
NO 
EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample Dark green colour  
2. Solubility: 
a. A little of the sample is 
shaken will with distilled 
water 
b. A little of the sample is 
shaken well with con 











Absence of silicate 
3. Action Of Heat: 
A small amount of the sample 
is taken in a dry test tube and 
heated gently at first and then 
strongly 
 
White fumes gas not 
evolved 
 
No brown fumes 
 
Absence of carbonate 
 
Absence of Nitrate 
4. Flame Test: 
A small amount of the sample 
is made in to a paste with con. 
HCl in a watch glass and 
introduced into non-luminous 
part of the bunsen flame 
 
 
Bluish green colour 
flame is appeared  
 
 
Presence of copper 
 
5. Ash Test: 
A filter paper is soaked into a 
mixture of sample and add 
cobalt nitrate solution and 
introduced into the bunsen 
flame and ignited 
 
Yellow colour flame not 
appeared 
 




PREPARATION OF EXTRACT: 5 gm of Nellivatral  choornam is weighed 
accurately and placed in a 250 ml clean beaker and added with 50ml of distiled water. Then it is 
boiled well for about 10 minutes. Then it is cooled and filtered in a 100ml volumetric flask and 
made up to 100ml with distilled water. 
SL.NO EXPERIMENT OBSERVATION INFERENCE 
1 Test for Acid Radicals   
1. Test For Sulphate: 
2 ml of the above prepared 
extract is taken in a test tube,  
to this,  add 2ml of 4%  
ammonium oxalate solution 
 
Cloudy appearance  








2. Test For Chloride: 
2 ml of the above prepared 
extract is added with dil. HNO3 
till the effervescence ceases. 
Then 2ml of silver nitrate 







Absence or Chloride 
3. Test for Phosphate: 
2ml of the extract is treated with 
2ml of ammonium molybdate 
solution and 2ml of Con. HNO3 
 




Absence of Phosphate 
4. Test for Carbonate: 
2ml of the extract is treated with 








Absence of Carbonate 
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5. Test for Nitrate: 
1gm of the substance is heated 
with Copper turning and 
concentrated H2SO4 and viewed 









Absence of Nitriate 
6. Test for Sulphide   
1 gm of the substance is treated 
with 2ml of Con. HCl 
 
 
Colourless,  No 




Absence of sulphide 
7. Test for Fluoride & Oxalate: 
2ml of extract is added with 2ml 
of dil acetic acid and 2ml of 








Absence of fluoride and 
oxalate 
8. Test for Nitrite: 
3 drops of the extract is placed 
on a filter paper,  on that 2 
drops of acetic acid and 2 drops 




Absence of Nitrite 
9. Test for Borate: 
2 pinches of the substance is 
made into paste by using 
sulphuric acid and alcohol (95% 
) and introduced into the blue 
flame 
 
Bluish green colour 
flame  is not 
appeared 
 
Absence of Borate 
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II 
Test for Basic Radicals   
1. Test for Lead 
2ml of the extract is added with 2ml of 





Absence of lead 
2. Test for Copper 
a. one pinch of substance is made 
into paste with con. HCl in a 
watch glass and introduced into 
the non-luminous part of the 
Bunsen flame. 
b. 2ml of extract is added with 
excess   
      of ammonia solution 
 





Appears  blue flame 
 





Presence of copper 
3. Test for Aluminum: 
To the 2ml of the extract sodium 







4. Test for Iron 
a. To the 2ml of extract add 2ml 
of Ammonium Thiocyanate 
solution 
b. To the 2ml of extract add 2ml 
of ammonium thiocynate 
solution and 2ml of con HNO3 
is added 
 
Blood red colour is 
not appeared 
 
No red colour 
developed 
 
Absence of Iron 
 
 
Absence of Iron 
5. Test for Zinc 
To 2ml of the extract sodium 










6. Test for Calcium: 
2ml of the extract is added with 2ml of 
4%  ammonium oxalate solution 
 
Cloudy appearance 





7. Test For Magnesium: 
To 2ml extract sodium hydroxide 
solution is added in drops to excess 
 





8. Test For Ammonium: 
To 2ml of extract few ml of  Nessler’s 
reagent and excess of  sodium 
hydroxide solution are added 
 
Mild brown colour 







9. Test For Potassium: 
A pinch of substance is treated with 2ml 
of sodium nitrate solution and then 
treated with of cobalt nitrate in 30%  
glacial acetic acid  
 
Yellow precipitate 







10. Test For Sodium: 
2 Pinches of the substance is made into 
paste by using HCl and introduced in to 
the blue flame,  of Bunsen burner 
 
Yellow colour 






11. Test For Mercury: 
  2ml of the extract is treated with 2ml 












12. Test For Arsenic: 
2ml of the extract is treated with 
2ml of silver nitrate solution 
 










1. Test For Starch: 
2ml of extract is treated with weak 
Iodine solution 
 
No blue color 
developed 
 
Absence of Starch 
2. Test for Reducing Sugar: 
5ml of Benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boil it for 2 minutes. The 





Presence of Reducing 
Sugar 
3. Test for the Alkaloids: 
a. 2ml of the extract is treated 
with 2ml of Potassium 
Iodide solution. 
b. 2ml of extract is treated 
with 2ml of picric acid. 
c. 2ml of the extract is treated 
with 2ml of 
Phosphotungstic acid. 
 













Presence of alkaloid  
 







4. Test for Tannic Acid: 
2ml of extract is treated with 2ml 
of ferric chloride solution 
 
Black precipitate is 
obtained 
 
Presence of Tannic 
Acid 
5. Test for Unsaturated 
Compounds: 
To the 2ml of extract 2ml of 











6. Test for Amino Acid: 
2 drops of the extract is placed on 
filter paper and dried well 
 
Violet colour not 
obtained 
 
Absence of amino 
acid 
7. Test for Albumin: 
2ml of the extract is added with 
2ml of ESBOCH’s reagent 
 
Yellow colour not 
precipitate is formed 
 
Absence of Albumin 
8. Test For Type of Compound: 
2 ml of the extract is treated with   
2 ml of ferric chloride solution 










No violet colour 
developed 
 










(ii) pyrine Aliphatic 
amino acids and 
meconic acid are 
absent 
(iii) Apo morphine 
salicylate and 
resorcinol are absent 
(iv) Morphine,  
Phenol,   absent 
 





LOSS OF DRYING 
5 gms of materials is heated in a hot oven at 105oC to constant weight. The percentage of 
loss of weight was calculated. 
DETERMINATION OF ASH VALUE 
Weigh accurately 2-3 gms of sample is tarred platinum of silica dish and incinerate at a 
temperature not exceeding 550oC until free from carbon,  cool and weigh. Calculate the 
percentage of ash with reference to the air dried drug.  
ACID INSOLUBLE ASH 
Boil the ash for 5 minutes with 25ml of 1:1 dilute HCl. Collected the insoluble matter is 
Gooch – crucible on an ash less filter paper,  wash with hot water and ignite,  cool and weight. 
Calculate the percentage of acid insoluble ash with reference to the air-dried drug. 
WATER SOLUBLE ASH 
To the Gooch crucible containing the total ash,  and 25ml of water and boil for 5 minutes. 
Collect the insoluble matter in a sintered glass crucible or on ash less filter paper. Wash with hot 
water and ignite in a crucible for 15 minutes at a temperature not exceeding 450oC. Subtract the 
weight of the insoluble matter from the weight of the ash; the difference of weight represents the 
water soluble ash. Calculate the percentage of water soluble ash reference to the air dried drug. 
ALKALINITY OF WATER SOLUBLE ASH 
5gms converted to ash,  boiled with water filtered,  filtrate was titrated against 0.1 N of 
HCl using phenolphthalein as an indicator. 
 Alkalinity of water soluble ash = X x of acid / 0.1 x W. 
 X = Titre value 
 W = Weight of the materials taken 
 Alkalinity is given as ml of 0.1 N of HCL equal to 1 gm 
pH  AT 10%  AQUEOUS SOLUTION 
5 gms of Nellivatral chooranam is weighed accurately and placed in clear 100 ml beaker. 
A few drops of aquaregia was added and evaporated by heating for few minutes. After cooling 
the content,  50 ml of distilled water is added to it and dissolved well. Wait for 30 minutes and 





To determine the metals and minerals in Nellivatral chooranam. 
INSTRUMENT 
Atomic Absorption Spectrometer with Air – acetylene. 
APPARATUS AND EQUIPMENT 
 500 ml glass beakers,  hot plate,  watch glass,  100 ml standard flask. 
CHEMICALS 
 Nitric acid,  hydrochloric acid,  certified reference standards. 
SAMPLE PREPARATION 
Transfer a weighted sample in to a 50ml beaker. Add 10ml of 1 + 1 HNO3 and 10 ml of 
1+1 HCl and heat on a hot plate until the sample gets dissolved. Cool and filter to remove 
insoluble material. Transfer sample to 100 ml volumetric flask,  adjust volume to 100 ml and 
mix. Take all precautions to avoid contamination at all stages. Prepare a reagent blank containing 
same amounts of acids used in the preparation of sample Aspirate the standards and sample into 
AAS instrument as per instrument procedure. 
CALCULATION 
 Percentage of the element = A / B x 100 
  A:  Concentration of sample in ppm 
  B:  Dilution factor 













ACUTE TOXICITY STUDIES OF NELLIVATRAL 
CHOORANAM 
 The present study was aimed at investigating the gross behavioral changes,  toxicological 
symptoms and approximate lethal concentration while administering acute gradual increase in 
dose levels orally. 
MATERIALS AND METHODS 
Animals 
 Randomly bred adult Wistar male and female rats from animal facility were used. They 
were housed in poly-propylene cages (6 per cage) with dust free rice husk as bedding material,  
and were provided with food and water ad libitum and rats for acute toxicity studies. The rats for 
acute toxicity studies were fasted for 18 h before the experiment.  
 Three male and three female rats (200 to 250 g body weight) of seven group of animals 
were given upto the maximum of 4.0g.kg-1 of orally at different dose levels from the beginning 
of 50mg/kg using a 16 gauge oral feeding needle as per the OECD guidelines-420. An equal 
number served as control,  given orally the vehicle only (3ml.kg-1 honey). Twenty-four hours 
after the oral dosing the animals were observed for physical signs of toxicity.  
Test drug 
 Nellivatral Chooranam was prepared as a suspension with honey by mixing all the 
constituents and used  for acute toxicity studies.  
 
ACUTE ANTIINFLAMMATORY ACTlVITY OF NELLIVATRAL 
CHOORANAM 
INTRODUCTION 
 Inflammation is body’s response to inactivate or destroy the invading organisms,  remove 
irritants and set stage for tissue repair. Inflammation is triggered by the release of chemical 
mediators from the injured tissues and migrating cells. The specific chemical mediators vary 
with the type of inflammatory process and include amines such as histamine,  serotonin,  lipids 






 Anti-inflammatory test was performed by employing wistar rats of either sex,  weighing 
100-120g (6 per group). They were arranged in three groups,  for each drug one served as 
control. In order to develop a new,  safe and effective anti-inflammatory drug a suspension was 
prepared with honey,  which served as the vehicle for drug delivery. Test group received 
400mg/kg of Nellivatral Chooranam orally. Honey replaced Nellivatral Chooranam in control 
animals. Right hind paw oedema was induced by subplanter injection of 0.1 ml of chemical 
mediator 2%  formalin. The volume of treated and untreated paw was measured before and at 15,  
30,  45,  60 and 120 minutes after the formalin injection by plethysmometric method in 
predetermined intervals. Results were statistically analysed using Student’s ‘t’ test. The 
percentage inhibition in paw oedema was calculated. 
EVALUATION OF ANTIHISTAMINIC ACTIVITY OF NELLIVATRAL 
CHOORANAM 
INTRODUCTION 
 Antihistaminics are used in symptomatic treatment of rhinitis,  sneezing,  rhinorrhoea,  
basal itch etc. However,  many of them produce drowsiness and CNS depression. The drug 
Nellivatral chooranam has been indicated for Peenism. It is believed that this drug will have 
good action against eczema. And also shown promising antiallergic activity in cases of rhinitis 
and is found to be devoid of side effects with very low incidents of side effects. This observation 
prompted us to evaluate the antihistamine effect of Nellivatral Chooranam in guinea pig ileum 
preparation. The histamine wheal test was performed on the dorsal area of guinea pig by 
injecting 2 µg of histamine phosphate in 0.1 ml of distilled water by the intra dermal route,  The 
erythema and wheal were observed 15 min after the injection and noted by outlining the margins. 
The same dose was applied in invitro method also.  The findings were comparable to those of 
invitro results. A single dose of Nellivatral Chooranam showed significant antihistaminic 
activity,  which distinguished it from conventional antihistaminics. The mechanism of action 





PREPARATION OF GUINEA PIG ILEAL STRIP: 
 Briefly,  the abdomen was cut open and the small intestine segment of the ileum (4 cm 
long) was removed 10 cm from the caecum,  and cleaned and suspended in a 20 ml organ bath 
containing Tyrode solution (composition,  mmol/L; NaCl,  136.0; KCl,  2.7; CaC12,  1.8; MgC12,     
1 .O; NaH2P04,  0.3; glucose,  5.5 and NaH2C0s,  12.0) maintained at 37°C and gassed with air. 
The preparation was allowed to equilibrate under a resting tension of 0.5g for 30 min during 
which the Tyrode solution was changed at 20 min intervals. Isotonic contractions with 
magnification x 7 were recorded on a smoked paper through a frontal writing lever. The dose 
response curve of histamine was recorded and the 0.1ml of Nellivatral Chooranam 1mg/ml 
solution was added to the tissue organ bath and irrigated for 30minutes. Then the three middle 
dosed responses of histamine was recorded in the presence of Nellivatral Chooranam.  In the 
above experiment the pH of the Nellivatral Chooranam,  before adding to the organ bath,  and 
when in the bath was measured. Contact time of Nellivatral Chooranam or standard agonist with 















 ePHf;Nfhit> %f;F ePHgha;jy;> gPdrk; vd;gdthk;. 
,ay;G 
%f;fpd; Jisf;Fs; rpte;J Jk;ky;> fz;rpte;J ePHtbjy;> %f;F ePHgha;jy;> 
jiyNehjy;> mbf;fb %f;ifr; rpe;jpr; rsp rPo;> FUjp ntspahjy; Mfpa  ,ay;Gila 
NehahFk;. 
Neha; tUk;top 
 kpFe;j FspHe;j ePiug; gUFjy; 
 gdp my;yJ FspHe;j fhw;wpyPLgly;. 
 Gif my;yJ GOjp gbe;Js;s fhw;iwr; Rthrpj;jy;.  vjpH fhw;wpy; 
nry;yy;. 
 Jk;kiyAz;Lgz;Zk; nghUs;fis KfHjy;. 
 cly; ntg;gkile;jpUf;Fk;NghJ Iaj;ijg; ngUf;ff; $ba FspHe;j ePhpy; 
jiy %o;fy;. 
 FspHr;rpahd nghUs;fis cl;nfhs;sy;. 
 jd; Njrky;yhJ> NtW ehLfSf;Fr; nrd;W> mq;F rpy rkak; mRj;jkhd 
ePiu cgNahfpg;gjpdhYk;. 
 mjpfk; cuj;Jg; NgRtjpdhYk; 
 msTf;F kpFe;jhtJ> Fiwe;jhtJ epj;jpiu nfhs;syhYk; %f;filg;G 
NehAz;lhFk;. 
 md;wpAk; Nkf Neha;f;Fj; Jizaha; ,e;Neha; tUtJz;L. 
 xf;f (Nahf) epiyapYs;sNghJ fPo; tha;f;fdy; (%yr;R+L) kpFjpahfpj; 
jiy %is tiuapw; nrd;W mq;F ntg;gj;ijAz;lhf;fp %f;filg;G 
Nehia tpistpf;F nkdTk; $WthWKsH. 
 
Kw;Fwp Fzq;fs; 
 %f;fpy; xUtif vhpr;rYk;> eikr;rYk; jhq;f Kbahjgb cz;lhtjhy; 
%f;F Kidiaj; Nja;j;Jr; rptf;fr; nra;jy;; 
 gpwF fz;fs; rpte;J fz;zPH tbjy;; 
 %f;ifailj;jhw;Nghy; NgRjy;; 
 jiyNeha; 
 %r;Rj; jpzwy; (%r;R cs;thq;fTk; ntsptplTk; Kbahik) 




  “gPdpre;jhd; tuyhW nrhy;yf; Nfz;kpd; 
   NgjKld; fdnyOk;gp tha;TQ; NrHe;J 
  CDUfp kz;ilapNy njhFf;fg;gl;L 
   AWjpAld; tha;tq;Nf AWj;Jg; gpd;Dk; 
  <dKl NdhLk; ePH rPop uj;jk; 
   gpbj;JtU tJfhJ %f;fp NdhL 
  NjdUtp te;jJ Nghy; nrq;fy; rpwhAQ; 
   NrHj;JtpOk; gPdprj;jpd; nra;if ahNk” 
 vd;gjhdy;> clw; fdYk;> thAk; NrHe;J NknyOk;gp kz;il %isiaj; jhf;fpf; 
nfhjpg;Gz;lhf;fp ,e;Nehiag; gpwg;gpj;J ePH> rPo;> uj;jk; ,tw;iwf; fhjpYk; %f;fpYk; 
tbar; nra;J %f;fpypUe;J nre;epwkhd rpwha; ntspNaWnkd mwpf. 
Neha; vz; 
,e;Nehiar; rpyH vz;gj;jp MW vdTk;> rpyH gjpndl;L vdTk;> jkpo; E}y;fspy; 
,jid xd;gJ tifahfTk; gphpj;Js;shHfs;. 
xd;gJ tif %f;filg;G Neha;fshtd 
1. tsp %f;filg;G 
2. moy; %f;filg;G 
3. Ia %f;filg;G 
4. ePH %f;filg;G 
5. FUjp %f;filg;G 
6. rPo; %f;filg;G 
7. rpwha; %f;filg;G 
8. %is %f;filg;G 
9. fOj;J %f;filg;G 
      vd;gdthk;. 
 
FwpFzq;fs; 
1 tsp %f;filg;G Neha; 
 %f;F> new;wp> GUtk;> fz;fs;> fhJfs;> tha; ,tw;wpy; VNjh GOCWtJ 
Nghd;w czHr;rp my;yJ eikr;rYz;lhjy;. 
 %f;filj;Jr; rpW rpW Jspahf ePHtbjy; 
 Jk;ky;> %f;fpy; FiltJ NghypUj;jy;. 
 fz;fs;> jiy> gy;> ,itfs; Nehjy;> thAyHjy;> Fuw;fk;ky;> cly; 




2. moy; %f;filg;G Neha; 
 %f;fpy; vhpr;ry;> %f;Fj; jz;Lk; cl;rijAk; rpte;J fhzy;. 
 %f;F ehw;wkwpahik. 
 %f;fpy; rpy Ntis nfhg;Gsk;> Gz; Kjypad cz;lhjy; Mfpa Fwp  
Fzq;fisg; gpwg;gpf;Fk; 
3. Ia %f;filg;G Neha; 
 Muk;gj;jpy; jiy Neha;> fz;zPH tbjy;> fz; rptj;jy;> %f;filj;jy;> 
%f;fpYz;lhFk; vhpr;ry;> eikr;ry; ,tw;iwj; jhq;fhJ %f;iff; ifahy; 
Nja;j;jy; 
 rsp KjpHe;J fl;bahf ehw;wj;NjhL ntspahjy; 
 fhjilj;Jf; fhJ rhpahff; Nfshik> rpy rkak; fhjpypUe;Jk; ePH tbjy; 
 ehr;Ritawpahik Mfpa Fwp Fzq;fisf; fhl;Lk;. 
4.  ePH %f;filg;G Neha; 
 %f;fpypUe;J tbAk; ePH kpfj; njspthf ,Uf;Fk; 
 jiyNeha;> rpWRuk;> Nrhk;gy;> if>fhy;fs; Nehjy;> Mfpa Fwp 
Fzq;fisf; fhl;Lk;. 
5.  FUjp %f;filg;GNeha; 
 cly; ntg;gkilAk; NghJ kz;ilapYk;> FUjpapYk; nfhjpg;NgWk;. 
 %f;fpd; cs;ghfk;> cjL> ehf;F ,it rpte;J Gz;Nghy; fhzy;. 
 %f;fpDs; vhpr;ry;> eikr;ry;> jpkpHjy;> my;yJ Nehjy;> fz; vhpr;ry;>  
fhJ Filjy;> jiy fOj;J> jhil Nehjy;. 
 kz;ilapyhfpYk;> %f;fpyhfpYk;> mbgbDk; %f;fpy; FUjp ntspahFk;.  
kw;Wk; FUjpaoy; NehapYk; ,isg;G NehapYk; Kw;Fwpahf %f;fpypUe;J 
FUjp tUtJKz;L. 
6.  rPo; %f;filg;G Neha; 
 %f;filj;J % r;Rtpl Kbahik> thahy; %r;Rtply;. 
 %f;Fr; rspahdJ fbdg;gl;L ehw;wkhff; fhzg;gly;. 
 %f;fpd; jz;bDs; xU Gwk; rpte;J tPq;fpAk;> kw;NwhHGwk; tw;wp 
cyHe;jhw;NghYk; fhzy;. 
 rspapd; ehw;wKk;> Nehapdd; tpLk; %r;Rk;> jhq;f KbahjthW JH 
ehw;wkhapUg;gpDk;> NehapdDf;F me;ehw;wk; my;yJ mk;kzk; 
njhpahjpUj;jy; Mfpa Fwp Fzq;fis tpistpf;Fk;. 
7.  rpwha; %f;filg;G Neha; 
 ,J Nkf Nehapidg; gw;wp tUtjhFk; 
 %f;F vYk;Gk; iee;J rpW rpW Jz;Lfshfr; rspNahL $b ,opAk;. 
 new;wpapd; fPo; gf;fKs;s %f;Fj; jz;L iee;J gs;sk; tpoe;J ehsiltpy; 
mOfp mjidj; Jisj;JtpLtJKz;L. 
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8. Kis %f;filg;G 
 %f;fpDs; cs;s rt;itg; gw;wpj; njhlHe;J fk;gspg; G+r;rpg; Nghy; my;yJ 
rq;fk; gok;Nghy; rijg; gw;Ws;sjhfTk;> ahidj;jpg;gpypiag; Nghy; ePz;L 
rpW FUf;fs; xd;Nwhnlhd;W NrHe;jhw; NghYk; rpte;J jsjsj;Jk; fhZk;. 
 %f;fpypUe;J FUjpAk; rspAkpopjyhfpa Fwp Fzq;fisf; fhl;Lk;. 
9. fOj;J %f;filg;G 
 ,e;Neha; fOj;jpYz;lhFk; Fuw; fk;ky; Neha;f;Fk;> njhz;ilailg;G 
Neha;f;Fk; Jizahf %f;filg;ig Az;lhf;Fk; NehahFk;. 
             
Kf;Fw;w NtWghLfs; 
czthjp nray;fshy; cly; ntg;gkile;J> moy; kpFjpg; gLk;NghJ 
Iaj;ijg; ngUf;ff;$ba nray;fshy; Iak; ngUfp moiyakhfp ,e;Nehiag; 
gpwg;gpf;Fk;.  md;wpAk; xf;f (Nahf) epiyapy; fPo;tha;f;fdy; (%yr;R+L) kpfg; ngUfpDk;> 
mJ Nky; Nehf;Fq; fhypd; (cjhd thA) td;ikahy; kz;il tiuapy; gha;r;rYs;s 








Sinusitis refers to an inflammatory condition involving the four-paired structures 
surrounding the nasal cavities. Although most cases of sinusitis involve more than one sinus,  the 
maxillary sinus is most commonly invoved,  followed in frequency by ethmoid, frontal, and 
sphenoid sinuses. 
Normally mucus does not accumulate in the sinuses, which remain sterile, despite their 
adjacency to the bacterium-filled nasal passages. When the sinus ostis are obstructedhoweveror 
when ciliary clearance is impaired or absent the secretions can be retainedproducing the typical 
signs and symptoms of sinusitis. The retained secretions may become infected with a variety of 
pathogensincluding viruses bacteria and fung, sinusitis affects a tremendous proportion of the 
populationaccounts for millions of visits to primary care physicians each year and is the fifth 
leading diagnosis which antibiotics are prescribed. 
NON-INFECTIOUS CAUSES  
 Allergic rhinitis 
 Barotrauma 
 Chemical irritants 
 Illness such as nasal and sinus tumors (Squamous cell carcinoma) 
 Granulomatous diseases (Rhinoscleroma) 
 Acute infectious sinusitis causes  
VIRAL CAUSES  
 Rhino virus 
 Parainfluenza virus 
 Influenza virus 
 Bacterial causes  
 S.pneumoniae 
 Non typable haemophilus influenzae 
 S.aureus 
 Pseudomonas aeruginosa 
 Seraatia marcescene  
 Klebsiella pneumoniae  
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 Mucor  
 Absidia and 
 Cunninghamella  
COMMON SYMPTOMS 
 Nasal drainage 
 Nasal congestion 
 Facial pressure on pain and  
 Headache 
               Other non specific symptoms include coughsneezing and fever  
INVESTIGATIONS 
 X-Ray  


















SELECTION OF PATIENTS 
30 patients were selected from the out patient department of National Institute of Siddha, 
Chennai-47 by present inclusionexclusion and withdrawl criteria. 
CRITERIA FOR SELECTION 
INCLUSION CRITERIA            
 Age group 15- 70 yrs. 
 Willing to attend the OPD once in 7 days for 48 days.  
 
EXCLUSION CRITERIA 
 Tropical eosinophila  
 Dust allergy 
 Commom cold 
 Influenza 
 Malignancy 
    
WITHDRAWL CRITERIA 
 Trial drug intolerance. 
 Any acute illness during trial period 
LINE OF TREATMENT  
The drug Nelli vatral choornam was administered internally in a dose of 1gm B.d with 
honey before food for 48 days  
DIET RESTRICTIONS 
 Brinjal, Bitter guard, Sesban, Tamarind 
 Coolant foods and diet must be avoided.  
 Butter milk ice cream and cool drinks must be avoided. 
 Lime juice orange juice and grapes juice must be avoided. 
 Drink plenty of fluids to increase moisture within your body. 
 Advised to avoid cold water for drinking and bathing.advised to use hot water for 




THE FOLLOWING MAY INCREASE YOUR RISK FOR DEVELOPING SINUSITIS 
 Air pollution  and smoke 
 Asthma 
 Changes in altitude  
 Deviated nasal septum nasal bone spur or polyp 
 Gastroesophageal reflux disease (GERD) 
PREVENTION  
 Get an influenza vaccine each year. 
 Wash your hands frequently particularly after shaking hands with others.  
 Eat plenty of fruits and vegetables which are rich in antioxidants and other  
 chemicals that could boost your immune system and help your body resist  
 infection.  
 Reduce stress.  
 Avoid smoke and pollutants. 
 Use  a humidifier to increase moisture in your nose and sinuses.  
 Take decongestants during an upper respiratory infection.  

















All collected data were entered into computer using MS-Excel program and analysed 
using STATA software. The improvement shown after treatment in terms of clinical symptoms 
viz sneezing, cough, headache, nasal discharge, nasal congestion, tenderness in frontal region, 










 OBSERVATION  
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RESULTS AND OBSERVATIONS 
     Table-1      QUALITATIVE ANALYSIS 
            







Table-2     PHYSICAL PROPERTIES 
Sl. No. 
                  Parameter 
Results (% ) 
1.                   Loss of drying @105oC 0.15 
2.                   Ash value @550 C 5.10 
3.                   Acid insoluble ash 0.64 
4.                   Water soluble 18.89 
5. 
                  pH at 10%  aqueous solution 3.18 
6.                  Alkalinity as CaCo3 in water soluble Ash 0.36 
   
Table-3   QUANTITATIVE ANALYSIS 
Sl. No.                       Parameter 
Results 
1.                       Magnesium 770mg/kg 
2.                       Copper 14.7 mg/kg 
3.                       Zinc 69.8 mg/kg 










1                               Reducing sugar Present 
2                               Tannic acid Present 
3                               Magnesium Present 
4                               Copper Present 
5                               Zinc Present 
6                               Calcium Present 
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RESULTS OF ACUTE TOXICITY STUDY OF NELLIVATRAL CHOORNAM 
There was no significant change in rats administered 50mg/kg to 4.0 g/kg. Nellivatral 
Chooranam did not show any significant change compared to the control during the 4 h post 
administration period. A dose of 4.0 g/kg of Nellivatral Chooranam given orally did not alter the 
normal behavioural parameters. The animals did not show any considerable changes in general 
behavior till the maximum of 1000mg/kg dose. But from the dose of 2000mg/kg a few changes 
observed were also within normal limits like slight increased motor activity tremor Increased 
respiratory rate which was followed by restlessness. Nellivatral Chooranam is a nonirritant and 
has a better safety. Good stability and extremely low toxicity. So it can be concluded that the 
Nellivatral Chooranam is safe and non-toxic upto 4g/kg dose. Hence 400mg/kg can be used as a 





 ACUTE TOXICITY STUDY  
Table-4 Incremental dose finding experiment and its Signs of Toxicity of Nellivatral Chooranam. 
No Treatment Dose 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1 I 50 + - - - - + - - - - - - - - - - - - - - 
2 II 100 + - - - - + - - - - - - _ - - - - - - - 
3 III 250 + - - - - + - - - - - - _ - - - - - - - 
4 IV 500 + - - - - + - - - - - - - - - - - - - - 
5 V 1000 + - - - - + + - - - - - - + - - - - - - 
6 VI 2000 + - - - - + + - - - - - + + - - - - - - 
7 VII 4000 + - - - - + + - - + - - + + - - - - - - 
 
Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch Response 7. Increased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. Catatonia 12. Muscle relaxant 13. 
Hypnosis 14. Analgesia 15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Mortality 
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ACUTE ANTI-INFLAMMATORY ACTIVITY OF NELLIVATRAL 
CHOORANAM ON FORMALIN INDUCED RAT PAW EDEMA. 
The study of anti-inflammatory test indicates that Nellivatral Chooranam at 400mg/kg dose p.o. 
inhibited 43.09%  of formalin induced paw edema. Anti-inflammatory activity of Nellivatral 
Chooranam was insignificantly increased in all the other test intervals as compared to control. 
Whereas standard drug Aspirin produced 51.98%  inhibition. This further supports the clinical 
results that Nellivatral Chooranam anti-inflammatory activity. More work is needed to develop 
and confirm further invitro anti-inflammatory activity to minimize side effects and its promising 
long-term therapeutic efficacy.The results shows that Nellivatral Chooranam is having selective 
oedema suppressant activity which was dose and time related. These observations support the 
conclusion that Nellivatral Chooranam has antiinflammatory action probably by its anti 5-HT 
and anti PGEI activity. Between the edemogens Nellivatral Chooranam exhibited greater action 
against PGE. Further studies are needed to substantiate the present preliminary finding 
Table-5 Acute Anti-inflammatory activity of Nellivatral chooranam (NVC) and Asprin on formalin  induced rat paw edema. 
S.no 
Treatment Dose mg/kg) Mean increase in paw 
volume (ml) 
%  Inhibition 
1 Control 2ml/kg 0.731±0.050 - 
2 NVC          400 0.416±0.028** 43.09 




















Control / 2 ml /kg NVC / 400          Aspirin / 150
 
Significance relative to control **P<0.01; ***P<0.001; N=6 Values are mean + SEM. 
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EVALUATION OF ANTIHISTAMINIC ACTIVITY OF 
NELLIVATRAL CHOORANAM 
The pH of the bath solution before adding to the organ bath and in the organ bath 
remained at 7.0 Nellivatral Chooranam (1µg/ml) inhibited the contractions induced by the 
histamine. Concentration-response curves in the presence of Nellivatral Chooranam were 
progressively shifted to the right maximum response was achieved by higher concentration of 
Nellivatral Chooranam The results of this study may suggest the following. First the Nellivatral 
Chooranam may contain 5-HT like substances. Second the Nellivatral Chooranam may cause 
the release of 5-HT from the tissue. If the second possibility is considered then it may explain the 
relatively delayed onset of action of the Nellivatral Chooranam The nature of antagonism of the 
Nellivatral Chooranam may be competitive as there is a progressive shifting of the dose- 









    Table-6      AGE WISE DISTRIBUTION: 
Age Female Male 
15-30 yrs 10.0% 3.3% 
31-40 yrs 10.0% 3.3% 
41 -50 yrs 3.3% 13.0% 
51 - 60 yrs 16.5% 36.3% 
61 - 70 yrs 0.0% 3.3% 
 























According to age distribution 10% female and 3.3% male were in less 15-30 yrs  10.0%  
female and 3.3%  male were in 31-40 yrs 3.3 %  female and13%  male were in 41-50 yrs 16.5%  
female and 36.3 %  male were in 51-60 yrs  3.3%  male were in 61-70 yrs 
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Table. 7. IMPROVEMENT OF SIGNS AND SYMPTOMS 
 
Symptoms 
Before                       
Treatment (% ) 
After 
Treatment (% ) Improved (% ) 
Sneezing 100 6.7 93.3 
Cough 20  100 
Headache 100 3.3 96.7 
Nasal drainage 66.6 10 90 
Nasal congestion 96.6 6.7 93.1 
TFR 33.3 10 90 
TMR 63.3 5.26 94.7 
BSE 63.3 5.26 94.7 
 
TFR-tenderness in frontal region 
TMR-tenderness in maxillary region 


































Sneezing Cough Headache ND NC TFR TMR BSE
CLINICAL OBSERVATION
Before Treatment After Treatment Improved
 
According to clinical assessment patients having 93.35%  sneezing. 100%  cough 96.7%  
headache 90%  nasal drainage 93.1%  nasal congestion 90%  tenderness in frontal region 



































Drug – Nellivatral chooranam Dose – 1gm b.d with honey Diagnosis - Peenism No. of Days treated - 48days 
   
SL 
NO NAME A/S OP.NO SG SG CH CH HA HA ND ND NC NC TFR TFR TMR TMR BSE BSE   
        BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT   
1 Fathima bee 35/F AG4250   +    -    -    -    +    -    -    -   +    -    -    -   +    -   +    -   
2 Elantha raj 39/M AG2619   +   +    -    -    +   +    -    -    -    -    -    -    -    -    -    -   
3 Rutharakumari 37/M AG1524   +    -   +    -    +    -   +    -   +    -    -    -   +    -    -    -   
4 Raj kumar 28/m AG1935   +    -    -    -    +    -   +    -   +    -    -    -   +    -    -    -   
5 Kalivani 36/F AG4613   +    -    -    -    +    -    -    -   +    -    -    -   +    -    -    -   
6 Mery 44/F AG2404   +    -   +    -    +    -   +    -   +    -    -    -   +    -    -    -   
7 Prema 40/F AG2425   +    -    -    -     +    -   +    -   +    -    -    -    -    -    -    -   
8 Vanaja 20/F AG2447   +    -    -    -    +     -    -    -   +    -    -    -   +    -    -    -   
9 Arthi 22/F AG5039   +    -   +    -    +    -   +    -   +    -    -    -   +    -    -    -   
10 Puskala 49/F AG2556   +    -    -    -    +    -    -    -   +    -    -    -   +    -    -    -   
11 Raja 27/M AG5057   +    -   +    -    +    -   +    -   +    -    -    -   +    -   +    -   
12 Reavathi 39/F AG5062   +    -   +    -     +    -   +    -   +    -    -    -    -    -   +    -   
13 Gomathi 23/F AG5148   +    -    -    -    +    -    -    -   +    -    -    -   +    -    -    -   
14 SathiSelvi 40/F AG5729   +    -    -    -    +    -   +    -   +    -    -    -   +    -    -    -   
15 Rajagopal 37/M AG6022   +   +    -    -   +    -   +   +   +   +    -    -   +    -   +   +   
16 Ganga 60/F AG6208   +    -    -    -   +    -    -    -   +    -    -    -    -    -   +    -   
17 Ponnai 28/F AG6253   +    -    -    -   +    -   +    -   +    -    -    -   +    -    -    -   
18 Arasu 43/F AG1551   +    -    -    -   +    -    -    -   +    -   +    -    -    -    -    -   
19 Fathima  42/F AG6371   +    -    -    -   +    -   +   +   +   +   +   +   +   +   +    -   
20 Sekar 27/M AG6604   +    -    -    -   +    -   +    -   +    -    -    -   +    -    -    -   
21 Meenachi 33/F AG6660   +    -    -    -   +    -   +    -   +    -    -    -   +    -    -    -   
22 Selvam 27/M AG6620   +    -    -    -   +    -   +    -   +    -    -    -   +    -    -    -   
23 Arokiasamy 28/F AG6737   +    -    -    -   +    -   +    -   +    -    -    -        -   +    -   
24 Kaliarasi 42/F AG6706   +    -    -    -   +    -    -    -   +    -    -    -        -   +    -   
25 Vijayan 24/M AG7016   +    -    -    -   +    -   +    -   +    -    -    -   +    -    -    -   
26 Meenatchi 33/F AG6660   +    -    -    -   +    -   +    -   +    -    -    -   +    -    -    -   
27 Selvam  27/M AG6620   +    -    -    -   +    -   +    -   +    -    -    -    -    -   +    -   
28 Arokiaswamy 28/M AG6737   +    -    -    -   +    -    -    -   +    -    -    -    -    -   +    -   
29 Kalaiarasi 42/F AG6706   +    -    -    -   +    -    -    -   +    -    -    -    -    -    -    -   
30 Vijayan 24/M AG7016   +    -   +    -   +    -   +    -   +    -    -    -   +    -    -    -   
 
SG  -   Sneezing HA -   Headache 
 
TFR -  Tenderness in frontal  region BSE  -  Burning  sensation in eyes. 
  
     CH -   Cough TMR -  Tenderness in maxillary  region           NC-Nasal congestion 
 
 LAB INVESTIGATION AT THE TIME OF TREATMENT 
S.NO NAME AGE/ SEX OPNO BLOOD URINE 




























































































































       P L E M ½ hr 1hr       PC EC 
BT 13.5 7800 56 39 4 1 12 24 4.5 90 18 0.7 Nil Nil 1-2 2-.3 1. Fathima bee 35/F AG4250 
AT 13.3 7500 56 40 6 2 6 12 4.2 95 15 0.8 Nil Nil 2-3 2-3 
BT 14.0 6800 50 48 2 - 3 6 4.6 74 20 0.6 Nil Nil 1-2 1-2 2. Elantharaj 39/M AG2619 
AT 15.5 6900 56 45 5 - 2 4 4.2 78 18 0.8 Nil Nil 1-2 1-2 
BT 12.2 6900 56 38 4 2 10 20 3.8 118 23 0.8 Nil Nil 1-2 2-3 3. Rutrakumari 37/F AG1524 
AT 12 7500 50 48 2 - 2 4 3.8 98 19 0.8 Nil Nil 2-3 2-3 
BT 16.1 9000 50 48 2 - 2 5 5.1 112 24 0.8 Nil Nil 1-2 1-2 4. Rajkumar 28/M AG1935 
AT 16 8500 40 58 2 - 2 4 5.0 121 23 0.4 Nil Nil 1-2 1-2 
BT 12.9 9500 60 34 6 - 7 14 4.2 82 20 0.6 Nil Nil 1-2 2-3 5. Kalaivani 36/F AG4613 
AT 13 8500 50 48 2 - 7 14 4.2 82 20 0.6 Nil Nil 2-3 2-3 
BT 13.5 7200 55 42 3 - 8 20 4.5 96 25 0.7 Nil Nil 1-2 1-2 6. Punithavalli 32/F AG4599 
AT 13.2 7500 50 48 2 - 4 8 4.4 98 28 0.7 Nil Nil 1-2 1-2 
BT 12.1 6200 50 43 7 - 12 23 4.3 86 21 .8 Nil Nil 1-2 2-3 7. Mari 44/F AG2404 
AT 12 6500 58 40 2 - 7 4 4.2 80 23 .9 Nil Nil 2-3 2-3 
BT 12.5 6000 52 46 2 - 3 6 4.3 100 19 0.3 Nil Nil 1-2 1-2 8. Mohadmad 
rabi 
27/M AG4705 
AT 12.2 6500 50 48 2 - 4 2 4.2 102 17 0.3 Nil Nil 1-2 1-2 
BT 12.5 6000 52 46 2 - 3 6 4.3 100 19 0.3 Nil Nil 1-2 2-3 9. Ranganathan 59/M AG4715 
AT 12.2 6500 50 48 2 - 2 4 4.2 102 17 0.3 Nil Nil 2-3 2-.3 
BT 11.6 9200 60 36 4 - 5 11 3.4 90 16 0.8 Nil Nil 1-2 1-2 10. Prema 40/F AG2425 








 LAB INVESTIGATION AT THE TIME OF TREATMENT 
S.NO NAME AGE/ 
SEX 
OPNO BLOOD URINE 





























































































































       P L E M ½ hr 1hr       PC EC 
BT 11.7 9900 58 35 2 - 10 22 3.4 112 17 0.7 Nil Nil 1-2 2-3 11. Vanaja 20/F AG2447 
AT 11.8 9000 50 48 2 - 2 4 3.5 100 19 0.7 Nil Nil 2-3 2-3 
BT 15.0 6500 55 44 1 - 6 15 5.0 130 20 0.6 Nil Nil 1-2 1-2 12. Madaswamy 28/M AG5022 
AT 15 6300 50 44 4 2 2 4 3.5 120 25 0.9 Nil Nil 1-2 1-2 
BT 15.2 7200 56 42 2 - 6 12 5.0 87 16 0.7 Nil Nil 1-2 2-3 13. Aarthi 22/F AG5039 
AT 15 7300 50 44 4 2 2 4 4.8 90 18 0.6 Nil Nil 2-3 2-3 
BT 13.6 7900 56 38 4 - 8 17 4.2 137 19 0.8 Nil Nil 1-2 1-2 14. Puskala 49/F AG2556 
AT 11.0 7300 50 46 3 - 13 26 3.2 131 17 0.6 Nil Nil 1-2 1-2 
BT 13.5 6700 52 46 2 - 4 8 4.5 78 26 0.7 Nil Nil 1-2 2-3 15. Raja 27/M AG5057 
AT 13.8 7000 52 48 2 - 2 4 4.6 86 25 0.8 Nil Nil 2-3 2-3 
BT 12.0 7700 54 43 3 - 10 22 4.1 94 18 0.5 Nil Nil 1-2 1-2 16. Revathi 32/F AG5062 
AT 12.2 7500 55 44 1 - 6 12 4.2 90 15 0.5 Nil Nil 1-2 1-2 
BT 11.2 5900 72 7 7 - 6 12 3.6 77 17 0.7 Nil Nil 1-2 2-3 17. Gomathi 23/F AG5148 
AT 11.2 6500 60 38 2 - 2 4 3.8 80 19 0.8 Nil Nil 2-3 2-3 
BT 14.1 7500 55 40 5 - 16 32 4.2 98 28 0.8 Nil Nil 1-2 1-2 18. Jagan 24/M AG5642 
AT 14.0 7800 40 55 5 - 8 16 4.1 100 25 0.9 Nil Nil 1-2 1-2 
BT 11.2 1000 62 32 6 - 18 34 3.4 81 32 0.5 Nil Nil 1-2 2-3 19 Sakthiselvi 40/F AG5729 
AT 11 7500 40 50 5 5 3 6 3.8 100 30 0.6 Nil Nil 2-3 2-3 
BT 11.0 7500 72 28 - - 24 48 3.1 100 38 0.9 Nil Nil 1-2 1-2 20. Rajagopal 37/F AG6022 








LAB INVESTIGATION AT THE TIME OF TREATMENT 
S.NO NAME AGE / SEX OPNO BLOOD URINE 






























































































































       P L E M ½ hr 1hr       PC EC 
BT 9.7 5900 55 40 4 1 10 22 3.2 99 35 1.1 Nil Nil 1-2 2-3 21. Ganga 60/F AG6208 
AT 10.0 6000 50 48 2 - 5 10 3.2 110 34 1.0 Nil Nil 2-3 2-3 
BT 12.6 6800 50 49 1 - 6 12 4.2 72 28 0.1 Nil Nil 1-2 1-2 22. Ponni 28/F AG6253 
AT 12.5 7000 50 48 2 - 2 4 4.2 80 28 0.1 Nil Nil 1-2 1-2 
BT 7.4 6300 50 38 1 2 33 68 2.2 94 26 0.8 Nil Nil 1-2 2-3 23. Arasu 43/F AG1551 
AT 7.8 7000 50 48 2 - 6 12 2.8 100 28 0.9 Nil Nil 2-3 2-3 
BT 8.3 9900 62 32 6 - 22 45 2.7 93 16 0.5 Nil Nil 1-2 1-2 24. Fathima 42/F AG6371 
AT 8.5 1000 50 45 5 - 10 20 3.7 100 15 0.4 Nil Nil 1-2 1-2 
BT 12.1 7900 55 40 5 - 4 8 4.0 70 22 0.8 Nil Nil 1-2 2-3 25. Sekar 44/M AG6604 
AT 12 7500 50 48 2 - 2 4 4.2 88 20 0.7 Nil Nil 2-3 2-3 
BT 12.1 7500 60 38 2 - 16 32 4.2 100 25 0.9 Nil Nil 1-2 2-3 26.. Meenatchi 33/F AG6660 
AT 12 8000 50 48 2 - 4 8 4.2 102 22 0.8 Nil Nil 2-3 2-3 
BT 15.0 8900 54 40 4 - 2 4 4.6 91 18 0.5 Nil Nil 1-2 1-2 27. Selvam 27/M AG6620 
AT 15 8500 52 46 2 - 2 4 4.3 100 20 0.7 Nil Nil 1-2 1-2 
BT 12.6 7900 54 43 3 - 5 10 4.1 124 17 0.7 Nil Nil 1-2 2-3 28. Arokiasamy 28/F AG6737 
AT 12 8000 52 44 2 - 2 4 - 130 18 0.8 Nil Nil 2-3 2-3 
BT 13.1 8700 54 44 2 - 5 10 4.2 174 21 0.6 Nil Nil 1-2 1-2 29. Kalaiarasi 42/F AG6706 
AT 13 9000 54 44 2 - 2 4 4.0 150 19 0.5 Nil Nil 1-2 1-2 
BT 15.5 9800 48 50 2 - 5 12 4.0 100 18 0.7 Nil Nil 1-2 2-3 30. Vijayan 24/M AG7016 












The following studies are confirmed the efficacy of Nellivatral Chooranam in  
management of  Peenism (Sinusitis)  
             Literary evidences were collected from various books about the drug. 
They all strongly support the anti-inflammatory action of Nellivatral Chooranam 
             Nellikai is used as a single drug or combination with other drug for the treatment of 
Peenism or Mookkadaippu or Neerkovai in many sidda literatures.Apart from these it was also 
indicated for erumal  kannerivu which are related symptoms of Peenism. 
Review of articles reveals the plant Emblica officinalis reveals anti microbial, 
immunomodulatory, antifungal, antibacterial, anti-inflammatory, spasmolytic, hypolidaemic, 
hypoglycaemic, antiathero sclerotic, HIV-reverse transcriptive inhibitory and antioxidant action. 
            The Bio-Chemical analysis of the drug Nellivatral Chooranam reveals the presence of 
Zinc Copper Magnesium Calcium Tannic acid and reducing sugar 
ZINC 
             Zinc may have secondary anti-oxidant activity may protect membranes against oxidatine 
changes. Zinc also comprises the structure of Copper/Zinc – superoxide dismatase [ca/zn-sod]. 
Zinc plays a structural role in ca/zn-sod. Zinc may also have anti-oxidant activity via its 
association with the copper binding protein metallo thionein. 
Zinc plays an important role in inflammation. Zinc levels are typically reduced in 
inflammatory conditions. Hence supplementation of zinc in inflammatory conditions may be 
ideal. 
COPPER 
           Copper is necessary for the formation of red blood cells and other components of the 
blood system and for the healthy growth development and maintenance of bone connective tissue 
brain heart and many other body organs. Copper like zinc and maganese is used to form anti-
inflammatory compounder in the body known as superoxide dismutase. Copper is a potent 
precursor of superoxide dismutase (SOD). Copper has a anti-inflammatory effect. 
CALCIUM 





               The properties of tannic acid are anti-bacterial anti-septic and anti-ulcer properties. 
Thus it works well in inflammatory conditions. 
PHARMACOLOGICAL STUDY 
              The pharmacological action of the drug Nellivatral Chooranam was carried out in Vel’s 
college of Pharmacy, PallavaramChennai. 
              Antiinflammatory activity in rat models using Wistar albino ratscarried out in 2% 
Formalin induced paw edema .The study gives satisfactory antiinflammatory result. 
              Antihistamine activity conducted in Guinea pigs ileum carried out by histamine 
phosphate induced hitamine activity. The study gives satisfactory antihistamine result. 
             Both pharmacological actions are effective at the dose of 400mg/kg  
CLINICAL STUDY 
 For the clinical study of Nellivartral Chooranam in Peenism in 30 patients were 
selected. According to  age distribution 10% female and 3.3% male were in less 15-30 yrs  
10.0%  female and 3.3%  male were in 31-40 yrs 3.3 %  female and 13%  male were in 41-50 
yrs. 16.5%  female and 36.3 %  male  were  in 51-60 yrs  3.3%  male were in 61-70 yrs 
 According to clinical assessment 93.3%  sneezing get relief 100% cough get relief  
96.7% headache get relief 93. 1% nasal drainage get relief 90% tenderness in frontal region get 
relief 94.7% tenderness in maxillary region get relief 94.7%  burning sensation of eyes get relief. 
Clinical study shows significant good results (94.64%) in management of disease 
Peenism (Sinusitis)  
IN SIDDHA ASPECT 









In this aspect Peenism is the derangement of azhal humor. 











The above text also proves it 
So the selected drug act well in management of  Peenism (Sinusitis)  
 























SUMMARY AND CONCLUSION 
 
SUMMARY 
The drug Nellivatral Chooranam has taken for the study to evaluate its efficacy in the 
management of  Peenism (Sinusitis). 
The literary collection describes the anti-inflammatory activity of Nellivatral 
Chooranam. 
  Review of journals describes rich source of vitamin C and antioxidant activity of fruit 
Nellikai  
            The Bio-Chemical analysis of the drug Nellivatral Chooranam reveals the presence of 
Zinc Copper Magnesium Calcium Tannic Acid and reducing sugar 
            Pharmacological studies showed that the drug has significant anti-inflammatory and 
antihistamine activity at the dose of 400mg/kg bw non-significant adverse effects. 
            The clinical study reveals significant good response (94.64%)in management of Peenism 
disease. 
Nellivatral chooranam is an easily available drug. 
Preparation of the drug is very easy 
 
CONCLUSION 
             It can be concluded that the anti-inflammatory and antihistamine activity may be due to 
presence of antioxidants. 
             From the pharmacological studies and clinical study concluded that the drug Nellivatral 
chooranam has significant anti-inflammatory and antihistamine activity. 























 Human beings are enjoyed all natural wealth in the world. They were also suffered 
innumerable diseases prevailing at that time. 'SIDDHARS' are those who lived and maintained 
their bodies as they desired best.  
 They have investigated that the body though transient was the one and only instrument 
for attaining success in the spiritual development and growth and so worked out to attain the 
eight supernatural powers as Anima Magima Lagima etc.  So they can have leading to eternal 
bliss.  
 They were the greatest scientists in ancient times. They choose not only to keep their 
bodies and souls together but also to prolong their lives to a considerable extent. 
 Siddha system of medicine is an ancient unique and potent system among all traditional 
system of medicine existing at present. 
 Siddha system believes that everything in the universe are made up of five basic elements 
earth water fire air and space which constitutes the human body and other worldly substances. 
Siddha system describes ninety six principal constituents of human beings which include 
physical physiological moral and intellectual components of individuals.  
 When there is any imbalance or slight deviation with these ninety six units diseases 
occur. The formulations in Siddha medicine include the herbal products in organic substances 
and animal products and lead to different formulations. All the metals and minerals used in 
Siddha system are completely in a detoxified state as per the method known 'Suddhi Muraigal'. 
During this process the metal molecules are rendered non-toxic. 
 It is well known that all the eyes of the world are tuning to the natural system of medicine 
especially Indigenous system of medicine to find out a more accepted drug for incurable diseases 
and minimal unwanted side effects of the drug. 
 We are using herbals minerals metals and living organisms for preparing medicines. 
Metallic preparations are consider as speciality of our system from other systems of Indian 
medicine. Lingam plays importanat role in curing many diseases. 
 According to Siddha pathology Karappan is due to derangement of kapha kutram 
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   “kieLt<t!Osk<Klf<ki!eqtgqz<!ouh<H?!
sblQjt!-Vlz</////////////////////////////!
! ! ! -Vk<Ovigr<!gvh<hie<!uqv{!Okiml<!!!! ! ! ! !
! ! ! ! //////////////////////////////////////////////////////////////////!
! ! ! !!!!!WPSvr<gt<!hzKg<gl!uqmL{<miOl”. 
! ! ! ! ! ! ! ! .!skg!fic!
 The drug Deepalinga chenduram is a compound drug having predominantly karppu and 
kaippu suvai .it is indicated for karappan. Karppu and kaippu suvai controls vatha humor. It is 





      )g{<[silqbl<*!
 As per mentioned in the above textthe compound drug Deepalinga chenduram  
containing karppu and kaippu suvai controls vatha humor.These literary evidences drove 
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AIM AND OBJECTIVES 
AIM 
 To evaluate the efficacy of Deepalinga chenduram in the management of Karappan 
(Eczema) in accordance with the reference made in Anuboga Vaithya Navaneetham part 4.  
 
OBJECTIVE  
 The clinical efficacy of Deepalinga chenduram has been evaluated in the following 
aspects. 
 Collection of evidences in siddha aspects.  
 Collection of evidences in chemical aspects. 
 Bio- Chemical analysis. 
 Physical Properties. 
 Quantitative analysis 
 Toxicological study. 
 Pharmacological analysis. 
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• -K! Olx<Og! gqpg<G! ur<glqVg<gqe<x! ljzbqe<! ncbqz<! -vsLl<?! ogf<kqBl<! gm<c!
d{<mibqx<X!we<Xl<!-ke<!hqxh<H!uvziX!%xh<hm<Mt<tK/!
OuXohbIgt<!
! N{<Gxq! ! giv{l<! ! utq!!
! -r<Gzqgl<! ! s{<mgl<! ! ue<eq!
! -visl<!! ! slvsl<!
! gjmue<eq! ! sieqbl<!
! gIh<hl<!! ! osf<K~vl<!
! gzqg<gl<! ! l{qvigl<!
! giR<sel<! ! lqOzs<sl</!
OuXohbIgt<!)OuX*3:!















! Ohkq?! Svl<?! sf<fqhikl<?! kQvih<! H{<gt<?! nkq&! k<kqvl<?! gi{ig<gcuqml<?! gisl<?!
gvh<hie<?!sqvr<G?!osiz<ukx<Gl<!hiIh<hkx<Gl</!ouXh<H!Okie<Xl<!hvU!F{ig<gib<!gqvf<kq?!



























wMk<K! S,kk<jkg<! gf<kgk<Kme<! dxuig<gq! oucBh<jh! gzf<K! gisqg<!
Gh<hqbqzjmk<K?! uiZjgbqzqm<M! NX! sill<! )29! l{q*! wiqk<K! Nxuqm<M!
dbIgl<hqzqr<gk<jk!wMk<Kg<!ogit<tUl</!
3/!hl<hib<!-zqr<g!juh<H!
! ! K~b<jlosb<k!-vsl<!! 8!hr<G!
! ! K~b<jl!osb<k!ogf<kgl<!! 3!hr<G!
 -u<uqv{<jmBl<! ye<xigs<! Osik<kjvk<K! vsl<! lcf<K! gVh<hie! hqe<! 8! sQjzl{<!
osb<KZi<k<kq!htqr<Gg<Gh<hqg<Gt<!OhimOu{<Ml<!
 lVf<kieK!Gh<hqbqz<!njvhigl<!Vg<gOu{<Ml</!

























! ! -vsl<!! ! !.!27!nUe<S!)591gq/*!
! ! ogf<kgl<! ! !.!!6!nUe<S)261gq/*!
 -u<uqv{<jmBl<!OsIk<K!dVg<gUl</!
 svg<Ggt<! ohir<gq! wPl<Hgqx! ujvbqz<! kQbqm<omiqk<Kh<! hik<kqvk<jk! nMh<jh!
uqm<cXg<gqs<! svg<Ggt<! kQh<hqcg<gilz<! hk<kqvlig! &ch<! hqxG! K~t<! osb<K!
Olx<g{<mhc!hkr<gqk<Kg<!ogit<tUl</!
7/!!liKjt!-zqr<g!juh<H!
! ! -vsl<!! ! .!2!hr<G!
! ! okim<ch<himi{l<!! .!2!hr<G!
 -u<uqv{<jmBl<!OsIk<kjvk<K!Olx<g{<mhc!hkr<gqk<K!wMk<Kg<ogit<tUl</!
8/!!-zqr<gl<!
! ! ogf<kgl<! ! .!23!hr<G!
! ! lOeisqjz! ! .!3!hr<G!
 -u<uqv{<jmBl<!OsIk<kjvk<K!nR<sel<!Ohizig<g!Ou{<Ml</!
 hqe<! 31! hr<G! vsk<jks<! OsIk<K! njvk<Ks<! osl<jlbie! ohicbie! hqe<H!





 npqR<sqx<! hm<jm! yV! uQjsjb! )2?511! gqvil<*! fXg<gq! ck<K! 5! hc! )6/3! zqm<mI*!
Htqk<k! gicbqz<! Ohim<M! -vU! heqbqz<! juk<K! lXfit<! gijz! fe<xib<! hqjsf<K!
gzg<gqbkqz<!2!hzl<!)46!gqvil<*!zqr<gk<jks<!sQjzbqz<!gm<cbqm<M!Olz<!sm<c!&c!2!
sQjz! l{<! osb<K! dzIk<kqh<! hqxG! heqbqz<! juk<okMk<K! nMh<Ohx<xq! uqtg<G!
Ohiz! fQI! ux<Xl<hc! wm<M! sill<! wiqk<K! wMk<K! Kjmk<K! Le<OhizOu?! Htq!
gVj{s<! s&zl<! gzf<k! gic! fQI?! fe<eiiq! OuI! gzf<k! gicfQI! -u<uqv{<cZl<!
keqk<keqbib<!wiqk<okMg<g!-K!Sk<kqbiGl</!

 hps<siX?! hSl<hiz<?! Oleqs<siX! -l<&e<jxBl<! sloujmg<! %m<c! -zqr<gk<kqx<Gs<!
SVg<gqm<omMg<g!-K!Sk<kqbiGl</!

 Ljzh<hizqZl<?! wZlqs<sr<geq! -vsk<kqZl<! LjxOb! yu<ouiV! fit<!
Dxjuk<okMg<gs<!Sk<kqbiGl</! ! !
dzIf<k! zqr<gl<! yVhzl<)46gq*47! )-K! yOv! gm<cbibqVg<g! Ou{<Ml<*!LSLSg<jgs<! s&.!









ogit<tOu{<Ml</! -K! yV! njvh<HmliGl</! hqxG! -zqr<gk<jkh<! ohick<K! Le<etU!
wZlqs<sl<! hps<six<jxs<! sqXgsqXg! uii<k<K! Le<Ohizjvk<K! Le<Ohiz<! uqz<jz! osb<K!
dzIk<kqg<!ogit<t!Ou{<Ml<//!-u<uqkl<!lmg<gq!lmg<gq!21!kmjugt<!osb<K!ogi{<miz<!
-zqr<gl<!Sk<kq!NGl</!
 -zqr<gl<! .! 2! hzl<<)46gq*! )-K! yOv! gm<cbqbibqVg<gOu{<Ml<*! kib<h<hiz<?! Oke<?!
our<gibs<siX?wZlqs<sl<hps<siX! -ju! fie<Gl<! ujgg<G! 2! Npig<G!





! ntU!! ! .!!! yV!Ge<xq)241lq/gq*!
! nEhiel<! ! .! ofb<?!Oke<!
! kQVl<Ofib<gt<!! .!! G]<ml<?!gVr<G]<ml<?!Olgv{l</!
3/ s{<Lg!kts<!osf<K~vl<27!
!!!!!ntU! ! ! .! 2!.!3!Ge<xq!)241.371lq/gq*!
nEhiel<!! ! .!! Oke<!)n*!ofb<!
kQVl<!Ofib<gt<!! .! Olg!sl<hf<klie!nPgqbv{r<gt<?!kqlqI!Gm<ml</!
4/ fivib{s<!osf<K~vl<27!
!!!!!ntU! ! ! .! 2!Ge<xq!)241lq/gq*!







































! gif<kl<?! S,kl<?! out<jth<himi{l<?! gUiq?! -zqr<gl<?! -ju! Yvtuig! wMk<K?!
ohie<eir<gi{qs<siX! uqm<M! 2! sill<! )4l{q*njvg<gUl</! -jk! dVm<c! jug<gUl</!!
jgbif<kgjvs<! six<jxs<! sQjzbqz<! kmuq?! nkqz<! -u<UV{<jmjb! juk<K! dVm<mUl</!!
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sm<cbqz<! 3! fipq)3//6zq<m<mi<)! dh<jhuqm<M?! nke<! Olz<! -jk! juk<K! OlOz! -v{<Mhc!







! OgiOvisje?! gif<kl<?! Gr<Glh<H,?! Ogim<ml<?! ngqz<?! sQvgl<?! niqkivl<?! sqXOkg<G?!
hupl<?!Lk<K?-Zh<jh?!-zur<gl<?!fe<eiiq?!uqzilqs<S?!ohie<olPG?!sikqzqr<gl<?!gz<fiI?!
gqvil<H?! Wzl<?! Lf<kqiqjg?! kg<Ogizl<?! kqh<hqzq! &zl<?! Lk<kg<giS?! gjzbqe<! ogil<H?!








! ntU!! ! .!½!Ge<xq)76lq/gq*!
! nEhiel<! ! .!Oke<?!Sg<Gk<K~t<!
! kQVl<Ofib<gt<!! .!gvh<hie<?!HxfQIg<Ogiju!
5 ff<kqjl5!
! ntU!! ! .!Okx<xie<!uqjk!












! Ouh<hLk<K! ofb<hc! ½! )2zq*! ?! -f<Kh<H?! gf<kq?! liz<Okuq?! our<givl<?! -zqr<gl<?!
Hr<gl<! uqk<K?! wVg<gl<! uqk<K?!-vsl<?! Gg<gqz<?! s{<hg! olig<G?! ohVr<gibl<?! sil<hqvi{q!


























• Sju!!! - uqXuqXh<Hm<e!%cb!jgh<H!giIh<H/!
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• uQiqbl<!! .! ouh<hl</!


























 STg<G! uqv{l<?! fjls<sz<! -jugm<G! -jkh<! ohick<K! OlZg<Gh<!!!!!!!!
H,szil</!
 hx<ohicBme<!jks<!sqxqK!OsIk<Kh<!hz<!Kzg<gquv!uib<!fix<xl<?!hx<HP!fQr<Gl</!
 gIh<h,vl<! 3! hr<G?! nhqeq! 2! hr<G! OsIk<Kk<! Oke<! uqm<mjvk<K! njv!
dTf<okjmg<G! )43lq/gq*! Olx<hmilz<! lik<kqjvbig<gqh<! hMg<GLe<! nVf<kquv?!
osih<he!^<gzqkl<?!fjls<sz<?!fim<hm<m!gQz<uiB!fQr<Gl</!
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 gIh<h,vl<?! gibl<! sloujm! wMk<Ks<! OsIk<K! 4dTf<okjm! lik<kqjvbig<gq!
dm<ogit<t!-jvh<H?!dh<Hsl<!Lkzqbe!fQr<Gl</!
















hbe<hMl<!dXh<H! ! ;! hqsqe<!
ORGANOLAPHIC CHARACTERS 
! Sju! ! ! .! giIh<H!
! ke<jl! ! .! ouh<hl<!
! hqiqU! ! ! .! giIh<H!
osb<jg!
! ouh<hL{<mig<gq! .!!! Stimulant 
! Ogijpbgx<xq!! .!!! Expectorant 
! kch<H{<mig<gq! .! Counter - Irritant 













































! Sju! ! ! .!!giIh<H!
! ke<jl! ! .!!ouh<hl<!
! hqiqU! ! ! .!!giIh<H!
osb<jg!
! ouh<hL{<mig<gq! .!!Stimulant 
! hsqk<kQk<K~{<c! .!!Stomachic 



































Sju! ! .! jgh<H?!giIh<H!
ke<jl! .! ouh<hl<!
hqiqU! ! .! giIh<H!
osb<jg!
! gixZ{<mig<gq! .! Acrid 
! ngm<Muib<ugx<xq! .! Carminative 
! Ljx!ouh<hgx<xq! .! Antiperiodic 
! kch<H{<mig<gq! .! Rubefacient 
! ouh<hL{<mig<gq! .! Stimulant 
! uQg<gr<gjvs<sq! .! Resolvent 
! uiklmg<gq! ! .! Antivatha 





! fisr<!gxqlqtgqeiz<” - )n/G*! ! !
! GtqIs<Svl<?! hi{<M?! Ogijp?! gpqs<sz<?! Ge<ll<?! uiB?! Sjubqe<jl?! ouxq?! &zl<?!






• lqtGk<K~t<! 21!gqvil<?! wVg<gl<! OuI! 29!gqvil<! wMk<K!hjeouz<zl<!kGf<k!ntU!
OsIk<kjvk<K!kqjebtU!lik<kqjv!osb<K?!yVlik<kqjv!kqel<!-VOujt!sih<hqm<M!
uv!ogiVg<GOfib<!G{liGl</!
• lqtGk<K~t<?! our<gibl<?! dh<H! -jugjts<! Osik<kjvk<Kk<! kjzbqz<! gi[l<!
HPoum<MgGh<!H,sq!uv!lbqI!Ljtg<Gl</!
• hx<ohic!osb<ukx<Giqb!ohiVm<gtqz<!yVLg<gqb!svg<G!lqtG/!
• lqtG! 62! gqvil<?! ohVR<sQvgl<! 79! gqvil<?! Oke<! 451! gqvil<! OsIk<K! -Ozgqblig<gq?!
gpx<sqgib<! ntU! kqelqVOujt! sih<hqm<Muv?! LkqObiVg<Gl<?! olzqf<OkiVg<Gl<!
d{<migqe<x!&zOfib<!k{qBl<!
lqtG!OsVl<!gvh<hiEg<gie!lVf<Kgt<!
1. ogicOuzq?! liuqzr<G?! kjzs<SVtq! -jugtqe<! -jzs<siX?! fz<oz{<o{b<29!
ujgg<G! 361! lq/zq! Olx<hc! OuIh<hjmjmgt<! &e<Xl<! ujgg<G! 29! gqvil<?! lqtG?!
out<jth<h,{<M?! gMg<gib<?! gmgOvigq{q?! gk<K~iq! lR<st<?! gVR<sQvgl<! ujgg<G! 25!
gqvil<! njvk<Kh<! Ohim<Mg<! gzf<K?! gib<s<sq! uck<K! 4! fit<! sih<hqm<M! 7! fit<! ujv!








out<tXG?! ogicOuzq?! lqtgvj{! OuI?! out<tigh<hm<jm?! sqXGxqR<sie<!







  5.  Karappan Kudineer57!
Ingredients 
1. Senkathari pattai (Capparis deciders) (Root bark). 
2. Milagu (Piper nigrum) (Fruit) 
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3. Chinni Elai (Acalypha fruticosa) (Leaves) 
4. Siru Kurinchan ver (Gymnea sylvestris) (Root) 
Method of preparation 
 One part of the powdered drug to be boiled in eight parts of waters and reduced to one by 
eight and should be used after decanting. 
 Dose: 30 – 60 ml twice daily 
kqh<hqzq!
PIPER LONGUM Linn 
OuX!ohbIgt<22!
! NIgkq! ! Ktuq!
! d{<svl<! ! ligkq!
! dzjufisq! ! Sje!
! gile<!! ! ost{<c!
! GOmiiq! ! k{<Mzq!
! Ogizgl<! ! g{l<!
! Ogizq!! ! gzqeq!
! OgijpbXg<gq! hi{l<!
! svl<! ! ! hqh<hqzq!
! sic! ! ! juOkgq!





! ! ! hs<js!.! dzIf<kK!
! Sju!!!.!! -eqh<H!.! dzIf<kK!
! ke<jl!.!!! km<hl<!.! ouh<hl<!








! =jt?! -Vlz<?! -jvh<H?! dh<hqsl<?! Lkzqb! hq{qgjth<! Ohig<gk<! kg<guiX!
kqh<hqzqjb!upr<gzil</!
hbe<gt<<!
 kqh<hqzqh<ohic!&uqvz<! ntju! gl<liX! oux<xqjzs<siXl<?! OkEl<?! YvtU! gzf<K!
dm<ogit<t!Ogijp?!-Vlz<?!Svl<!kQVl</!
 kqh<hqzq! S,v{l<! giz<! hzk<jk! 461! lq/zq/! hSuqe<! hizqz<! uqm<Mg<! gib<s<sqs<!
sih<hqm<Muv!-Vlz<?!uib<U?!&Is<js?!Lh<hq{q!-juOhil</!
 kqh<hqzqjbk<K~t<! osb<K! 2! likl<! ujvg<Gl<! Okeqz<! Gjpk<Ks<! sih<hqmk<! Oklz<!
fQr<Gl</!)Ok/!G*!
 kqh<hqzq! 6! hr<G?! Okx<xie<! uqjk! 4! hr<G! -ju! -v{<jmBl<! fe<xibjvk<Kh<!
ohick<K?! gPfQiqz<! 5! gqvil<! wjm! ntU! 4! fit<! gijz! OkiXl<! ogiMk<Kuv!
out<jt?!ohVl<hiM!kQVl</!
fug;ghDf;F jpg;gpyp NrUk; gpwkUe;Jfs; 
2/ sque<!Oul<H!$v{l<7!!
!!!!!!! ! nEhiel<.!squeii<Oul<H!Gpqk<jkzl< 
2. mKf;fuhNtH 140 fpuhk;> jpg;gpyp> Xkk;> jpg;gpyp %yk;> jphpgyh> gwq;fpg;gl;il> 
ePubKj;J tiff;F 35 fpuhk; rhjpf;fha;> rhjpgj;jphp> fpuhk;G tiff;F 13 fpuhk; 
-bj;J R+uzpj;J 1 fpuhk; tPjk; Njdpy; nfhLf;fyhl</ 
 
 fug;ghDf;F  jphpfLF NrUk; kUe;Jfs; 
 1. fpue;jp vz;nza;9 
msT  - YI!Npig<G)279!lq/zq/* 
jPUk;Neha;fs; - kz;ilfug;ghd;> tplf; fug;ghd;> tz;Lfb 
2. fug;ghDf;F vz;nza;8 
 mfj;jp> fHg;g+uts;sp> mThp> nts;sWF> rq;F> MlhNjhil> kzj;jf;fhsp> 
Mtiu> rq;fq;Fg;gp> epyf;flk;G> ehafk;> fUnehr;rp> KUf;F> <uTs;sp tiff;F 
cof;Fr;rhW nfhz;L MkZf;F vz;nza; 1 ehop (1.3zq* NrHf;fTk;.  mj;Jld; kQ;rs;> 
kukQ;rs;> fj;J}hp kQ;rs;> sqtij fLFNuhfpzp> jphpfLF> jphpgiy> Vyk; itfis 1 
tuhfd; (4.2gq* miuj;Jf; $l;lTk;.  ,ij nkOF gjkhff; fha;r;rp tbf;fTk;. msT - 
Mohf;F(168!lqzq*/  
4/!sgzgvh<hie<!sqvr<gqx<G!Olx<h,s<Sl<!w{<o{b<27!
! !!uqmk<kjz?! -jzg<gt<tq?! kqVGg<gt<tq?! sKvg<gt<tq?! liuqzr<G?! ogil<lm<c?!
Gh<jh! Oleq?! nUiq?! ohiMkjz?! fqzg<gml<H?! Nl[g<G! ofis<sq! -jugtqe<! siX!
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fz<oz{<o{b<! ujgg<G! hc! ¼?! uQkr<gzf<K! nkqz<! sQvgl<?! gMG?! Ogijvg<gqpr<G?!




ofb<?! wt<ofb<?! ujgg<G! yV! hc! uQkLl<! gzg<gq! nkqz<! gVR<sQvgl<?! lR<st<?! lqtG?!
kqh<hqzq?!Sg<G!Ngqb!-ux<jxg<!gx<glig!njvk<K!gzf<K!gib<s<sq?!uck<k!w{<o{jb!
dm<ogi{<Ml<!OlOzBl<!H,squv!osr<gvh<hie<!kQVl</!




! Lk<kg<giS?! K~Kujt?! gi{q?! osr<gPfQI?! Yiqjzk<kiljv?! squeiI! Oul<H?!
fqzOul<H?!Gh<jhOleq!sr<gqjz?!ljzkir<gq!ogie<jx!-jugtqe<!OuI!ujgg<G!hzl<.2?!
)46! gq*! Sg<G?! lqtG?! kqh<hqzq?! gMg<gib<?! -f<Kh<H?! gVR<sQvgl<?! usl<H?! gMgOvigqeq?!

















LINGAM (CINNABAR)  
 It is a kind of mineral substance mixed with sufficient quantity of padarasa (mercury) 
otherwise known as mercury II sulphide –Hgs (Red sulphide of mercury) 60 
 This is a combination of mercury and sulphur. Naturally available in mines. Artificially 
prepared lingam available in the market and are used in medicines.  
CHEMICAL FORMULA 
 Mercury (II) sulphide Hgs. 
IDENTIFICATION59 
 Colour    : Brownish red. 
Crystal ha                                : Rhombohedral to tubular 
      Granular to massive. 
Crystal system  : Hexagonal 
Cleavage   : Prismatic perfect 
Fracture   : Unevenis subconchoidal 
Lustre    : Adamantine to dull 
Refractive index   : Transparent  to opaque. 
Streak    : Scarlet 
Specific gravity  : 8-8.2g/cm³ 
Solubility    : 3.1026g / 100ml water 
Melting point    : 1450/120 atm 
Vapour pressure (mm) : 760/583.5ºC 
Molecular wt   : 232.68. 
NAMES FOR CINNABAR39 
 Hindi                                    -  Sinjraph 
 Maharashtra                        - Ingred 
 Guj                                      -  Hingalo   
 French names           - Cinabre 
           German names                         -           Cinnabarit Zinnabarit  Zinnober                                                                     
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 Italian names         -              Cinnabro 
 Spanish names        -              Cinabrio 
GENERAL CINNABAR INFORMATION 
Chemical Formula        :  Hgs 
Composition         :   Mercury     86.22 % Hg 
         Sulfur         13.78%  s 
                     100.00%  
Empirical Formula :  Hgs 
Environment :  Low temperature hydrothermal solutions in veins.  
IMA Status :   Valid Species(Pre-IMA) 800 
Locality :   Almaden Spain.                                         
Name Origin :   Of uncertain original meaning from the Latin  
    cinnabaris. 
Synonym :   Cinabre ICSD 70054 PDF 42-1408   Zinnober 
CINNABAR CRYSTALLOGRAPHY 
Axial Rations  :   a:c= 1:2.2885 
Cell Dimensions :   a=4.149c=9.495Z=3;V=141.55 Den (Calc)=8.19 
Crystal system :   Trigonal –Trapezohedral H-M Symbol (3 2)  
PHYSICAL PROPERTIES OF CINNABAR 
 Cleavage :  [1010]Perfect 
 Density  :  8.1 
 Diaphaniety       :   Transparent to translucent to opaque 
 Habit         :  Disseminated –Occurs in small distinct  
 particles dispersed in matrix.  
 Habit :   Druse-Crystal growth in a cavity which results in  
    numerous crystal tipped Surfaces 
 Habit :   Massive-Uniformly indistinguishable crystals  
    forming large masses. 
 Hardness :   2-2.5- Gypsum-Finger Nail 
 Luminescence   :   None. 
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OPTICAL PROPERTIES OF CINNABAR 
Dichroism(e) :   Cochineal red. 
Dichroism(w) :   Cochineal red.  
Polymorphism& Series :   Trimorphous with metacinnabar and  
                                               hypercinnabar.  
Association :   Mercury realgar pyrite marcasite stibnite “opal”  
         “chalcedony” barite dolomite calcite.  
Taste62 :  Acrid, bitter 
HISTORY 
 Cinnabar or red mercuric sulphide was used as for back as the pre Mycenaean Bronze age 
around 2000 BC to colour paint. Since it represents one of the few naturally occurring mercury 
components. its history is closely associated with that of mercury  which has been used throught 
out the centuries.  
 Mercury has been extracted from cinnabar since the 1st century. Burning off the sulphur 
contained in the compound converted the mercury into a highly poisonous vapour which was 
then condensed in the pure form (Hgs +O2 → Hg+SO2) 
 The use of mercury in medicine is almost as old as case of poisoning. In the 9th century 
Arabian doctors used ointments containing mercury to treat skin infections as well as parasitic 
eczematous and leprous infections. Inunction treatment using ointments containing mercury 
(grey salve) were applied to treat syphilis when the “French disease” as it was known then began 
to spread from country to country around 1490. 
 The Greek word kinnabari (cinnabar) is apparently derived form the Arabic word apar 
(Red dust) which is possibly of Indian or persion origin. The Roman term for cinnabar was 
‘minimum’ cinnabar was an expensive pigment used for painting and was often adulterated by 
lead or lead oxide. The name minimum which is etymologically related to the world for red lead 
soon became interchangeable with its surrogate.  
OCCURRENCE 
Cinnabar is the most frequent naturally occurring mercury compound.  
It can be found either pure or mixed together with other minerals. 
 72 
 In most cases cinnabar is to be found as a deposit remaining from hot aqueous solutions 
during periods of volcanic activity.  
 It is largely found in Almaden in spain Idria in Slovenia Italy Peru California Mexico 
Japan and Russia. 
 The vast proportion of Cinnabar is however Produced artifially from mercury and sulphur 
using various methods. 
PREPARATION OF CINNABAR AT LABORATORY 60. 
 One part of mercury and four parts  of the sulphur and to be placed in an iron pot and 
heated for some time. The amalgam is then to be broken into pieces and put into a glass bottle 
previously coated all round with mud and rag one inch deep and dried in shade. The bottle is to 
be heated for five days continuously by means of the five increasing gradually intensity at a 
uniform rate. The heating is then to be discontinued and the contents of the glass bottle taken out 
on the 7th day. The product will be found to be Cinnabar.  
 
TOXIC ASPECTS 56 
 Lingam is one of the poisonous compounds of mercury (i.e) mercuric sulphide 
(cinnabar). Artificial preparation occurs a red crystalline powder and is known as vermilion.  
SIGNS & SYMPTOMS OF LINGAM TOXICITY 
 Salivation Inflammation of gums and occasionally a blue line at their junction with teeth 
sore throat and mouth loosening of teeth gastro intestinal disturbances anemia anorexia and  loss 
of weight. 
CHRONIC POISONING 
 This may result from 
1. Continuous accidental absorption by the workers.  
2. Excessive therapeutic use. 
3. From recovery from a large dose.   
 
FATE AND EXCRETION  
 After absorption mercuric ion is distributed between blood cells and plasma. Excretion is 
by kidney liver colonic mucus membrane. It is also excreted in the saliva milk sweat and faeces 
if the quantity is larger.  
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 Fatal dose 1-4gm 
 Fatal period 3-5 days.  
,ypq;f eQ;Rf; FwpFzk;1 
 thab> cz;zhf;F> Fuy;tis> ngUq;Fly; Kjypad nte;J gRk;Gz;zhfpg; 
gUj;jpg; g+itf; frf;fp ntapypy; l;lhw; NghypUf;Fk;.  thapy; fhuk; gl KbahJ.  
czT> ePH Kjypad mUe;Jtjw;Fk;> NgRtjw;Fk; tUj;jj;ijf; nfhLf;Fk; thapy; 
nfl;l ehw;wk; tPrp> Ritnfl;L> tapw;wpy; vhpr;riyAk; cz;L gz;Zk;.  dkpo; ePH 




   rhjpf;fha;> thy;kpsF> nrk;gUj;jp NtHg;gl;il> fw;fz;L itfisj; jdpj;jdp 
xt;nthU tuhfndil (4.2 fpuhk;) vLj;J Kiwg;gb FbePhpl;L UNtis xU kz;lyk; 
mUe;j Ntz;Lk;. 
 
1. gUj;jp NtHg;gl;il FbePH jw;F KwpthFk;. 
 
2. “fy;yhjp Nyhfq; fspd; Fw;wkhwtay; 
 fy;yhjp Nuhfq;f fhpanahd;Nw” 
 
 vd;gjhy;> jhsfk;> NeHthsk;> ,ypq;fk;> ,urk;> fe;jfk;> ehgp> mgpdp> fQ;rh 
Mfpa ,itspd; Ntfj;jhy; NeHe;j gpzpfSf;Fg; nghJthf> kpsifg; nghbj;Jg; gRtpd; 
nea;apy; Nghrdj;Jf;F Kd; xUgpb rhj;jpw;F itj;J RLifAld; cl;nfhz;L kw;w 
czTfisg; gpd; Grpj;J te;jhy;> mJ cs;Swp md;durk; Kjypa Cz; nghUs;fis 
tpNuhjg; gLj;jhky;> ed;ikAz;lhf;fp> kUe;jpd; Ntfq;fisj; jzpf;Fk;.  md;wpAk; 
mk;kpsifNa FbePuhfr; nra;J> Gsp> kpsfha; itfisf; Fiwtha;r; NrHj;Jr; rhjj;jpy; 













CINNAMOMUM  CAMPHORA   Nees 
 
According to Benthem and  Hooker Classification. 
 Kingdom  - Plantae 
 Subkingdom  - Tracheobionata 
 Super division  - Spermatophyta 
 Division  - Magnoliophyta 
 Class   - Magnoliopsida 
 Subclass  - Magnotiidae 
 Order   - Laurales 
 Family   - Lauraceae 
 Genus    - Cinnamomum schaeff. 
 Species  - camphora (L) J. Presl. 
VERNACULAR NAMES36,43 
Tamil   - Karpooram                                        
Sans   - Karpoor 
Eng   - Camphor 
 Telugu   - Karpooram 
 Arab   - Kafoor 
 Guj   - Kapoor 
 Mal   - Karpooram 
 Ger   - Kamphor 
 Bom bay  - Bhimseni Kapur 
 Hindi   - Kapoor 
HABITAT 
 Found in Indian bazaars. It is generally imported from China and Japan. 
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PREPARATIONS 
 Pill Powder emulsions tincture spirits liniment and water or mixture.  
USES 
  In pruritis and   eczema of genitals camphor ointment is a very useful applications.  
  In uterine pains 6-8 grains pills are administered and the liniment of camphor is rubbed     
   on the abdomen. 
  It is good in typhus. 
  It is good in confluent small pox and all fevers and eruptions of the typhoid class. 
 
STYRAX BENZOIN   Dryand 
According to Benthem and   Hooker Classification.  
 Kingdom                     -          Plantae 
 Division   - Magnoliophyta 
 Class   - Magnoliopsida 
 Order   - Ericales 
 Family   - Styraceae 
 Genus    - Styrax 
 Species  - benzion 
VERNACULAR NAMES36,39,43 
            Tamil   - Sambirani 
 English  - Benzion tree 
 Mah   - Oodh 
 Hind   - Luban 
  It is native of Malay Penisula and Sumatra.  
 It contains Benzoic acid cinnamic acid Vanillin and Volatile oil. 
USES 
 Benzoin is antiseptic disinfectant stimulant and expectorant.  
 As diuretic it is useful in calculus disorders   from phosphatic  deposits in urine. 
 It is useful in jaundice and in incontinence of urine in children. 
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 Its compound tincture popularly known as Friar’s Balsam or traumatic balsam has been 
employed as a styptic and healing application. 
 It is also useful application to foul and indolent ulcers.  
PIPER NIGRUM  Linn 
According to Benthem and Hooker Classification. 
 Kingdom   - Plantae 
 Division   - Angiosperma 
 Class    - Dicotylydonae 
 Order    - Piperales 
 Family    - Piperaceae 
 Genus    - Piper  
 Species   - nigrum  
VERNACULAR NAMES11,39,41,55 
Tamil                            -           Milagu  
 Sans    - Maricham 
 Eng    - Black-Pepper 
 Ger     - Schwartage Preffer 
 Hind    - Gulmirch 
 Mal    - Kuru-mulaka 
 Can     - Volloy menasee 
 Beng    - Kalmirch 
 French    - Poivre 
           Tel    - miriyalu 
HABITAT 
 This perennial climbing shrub is indigenous to Malabar and Travancore coasts i.e  
western coast of India. 
CONSTITUENTS 
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 A volatile alkaloid piperine or pipirine 5 to 9 p.c. Chavicine is a soluble pungent concrete 
resin  it contains very little piperine and no volatile oil. Piperine crystallizes  in flat four sided 
glassy prisms insoluble in water.  
PARTS USED    
Dried unripe fruit black pepper.  
ACTIONS40,39 
• Anti inflammatory 




 Externally it is values for its  rubefacient  properties. 
 It is used as a local application for relaxed sore- throat piles and some skin  
 diseases.  
 Pepper is much employed as an aromatic stimulant cholera  weakness following  
 fevers vertigo coma. 
 In China pepper is considered an energetic stimulant diaphoretic and carminative.   
 
PIPER LONGUM   Linn 
 According to Benthem and Hooker Classification. 
 Kingdom   - Plantae 
 Division   - Magnoliophyta 
 Class    - Magnoliopsida 
 Order    - Piperales 
 Family    - Piperaceae 
 Genus    - Piper 
 Species   - longum  
 
VERNACULAR NAME11,39,41,55 
Tam    - Thippili 
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 San    - Pippali 
 Hind    - Pimpli 
 Guj    - Pipara 
 Punj    - Pipal 
 Mal    - Tippili 
 Malaya   - Lada 
 Nepal    - Pipla mol 
 Tel    - Pippali-katte 
 Eng    - Dried catkins 
HABITAT 
 This plant is indigenous to north-eastern and southern Indians and Ceylon and cultivated 
in Eastern Bengal. 
PARTS USED 







 Resin volatile oil  starch  gum fatty oil and an alkaloid piperine 1-2p.c  
USES 
 For catarrh and hoarseness a mixture of long pepper long pepper root black pepper and 
ginger in equal parts is a useful combination.   
 In Travancore an infusion of the root is prescribed after parturition with the view of 
causing the expulsion of the placenta.  
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 In dry cough a compound powder made up of equal parts of long pepper round zedoary 
ginger root of clerodendron siphonanthus karkadagashringi and raisins is very useful 
remedy given in doses of 30 grains with honey of treacle. 
 
 
ZINGIBER  OFFICINALE  Roscoe 
 
According to Benthem & Hooker classification. 
 Kingdom  - Plantae 
 Division  - Magnoliophyta 
 Class   - Monocotyledonae 
 Order   - Zingiberales 
 Family   - Zingiberaceae 
 Genus   - Zingiber 
 Species  - officinale 
VERNACULAR NAMES11,39,41,55  
         Tamil   - Chukku 
 Eng   - Zingiber 
 Ger   - Ingwer 
 Tel    - (dried)  sonti 
 Burm   - (dried) Ginsi-kyaw 
 Malay   - Hulya kring 
 Guj   - Adu 
 Hind   - Sonth 
   Sans   - Srangavera 
HABITAT 
 Ginger is cultivated in many parts of India on a large in the warm moist regions chiefly in 
Madras Cochin and Travancore and to a somewhat less extent in Bengal and the Punjab. 
 
PARTS USED 
 Scraped and dried rhizomes as well as the green ones. 
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 CONSTITUENTS 
 It contains camphene Phellandrene zingiberine cineol and borneol gingerol a yellow 





• Anti- inflammatory  





 Ginger is extremely valuable in dyspepsia flatulence colic vomiting and other painful 
 affections of the stomach.  
 Ginger juice mixed with sugar candy and given twice daily is a good remedy for  
 diabetes.  
 Malabar vaidyas hold that juice expressed from fresh ginger in gradually increasing  
 doses is a strong diuretic in cases of general dropsy. 
 In the collapse stage of cholera powdered ginger is rubbed to the extremities to check  



























MATERIALS AND METHODS 
METHOD OF PREPARATION 
 
PURIFICATION OF LINGAM1 
Lime juice Cow’s milk Kuppaimeni juice (Acalypha inidca) equal part The above three are 
mixed well. Lingam is kept on mud plate kept under flame. The above juice is added to 




1. Lingam  – 1 palam (35gm) 
2. Paal sambirani  – 1 palam (35gm) 
3. Deepa Karpooram  – 1 palam (35 gm) 
 
II. 
1. Chukku     –  ¼ Palam (8.75 gms) 
2. Arisi thippili  –  ¼ Palam (8.75 gms) 
3. Milagu     –  ¼ Palam (8.75 gms) 
PROCEDURE 
Sambirani and Deepa karpooram powdered well in kalvam and grinded for 3 hours until 
it becomes mezhugu consistency The above mezhugu made into 10 equal parts. One part is 
applied over piece of cloth then covered around the Lingam and kept under the flame. 
After completely burned out the covered ash is removed and 2nd part is used in the above 
method followed by remaining 8 parts. 
After the above process the Lingam is made into Lingakattu. 
Purified Chukku Arisi thippili and Milagu are roasted and powdered well in kalvam for 
one hour and collected in air-tight container. 
 
DOSE    : 65 mg 
 
THUNAI MARUNTHU : Honey  
 
INDICATION  : Kiranthi Kumattal Soolai Gunmarogam Vaayu Parangipun  
   Karappan Sogai Pandu Thoodangal Sanni Moorchai  
Madangal Vaayadaippu Kaikaal vellai. 






MATERIALS AND METHODS 
PREPARATION OF DRUG 
 












PEPPER DRIED CATKINS 
 
 

























1. Appearance of the sample Dark red colour  
2. Solubility: 
a. A little of the sample is 
shaken will with distilled 
water 
b. A little of the sample is 
shaken well with con 











Absence of silicate 
3. Action Of Heat: 
A small amount of the sample 
is taken in a dry test tube and 
heated gently at first and then 
strongly 
 
White fumes gas not 
evolved 
 





Absence of Nitrate 
4. Flame Test: 
A small amount of the sample 
is made in to a paste with con. 
HCl in a watch glass and 
introduced into non-luminous 
part of the bunsen flame 
 
Bluish green colour 
flame is appeared  
 
Presence of copper 
 
5. Ash Test: 
A filter paper is soaked into a 
mixture of sample and add 
cobalt nitrate solution and 
introduced into the bunsen 
flame and ignited 
 
Yellow colour flame not 
appeared 
 
Absence of sodium 
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PREPARATION OF EXTRACT 
 5 gm of Deepalinga Chenduram is weighed accurately and placed in a 250 ml clean 
beaker and added with 50ml of distiled water. Then it is boiled well for about 10 minutes. Then it 
is cooled and filtered in a 100ml volumetric flask and made up to 100ml with distilled water. 
 
SL.NO EXPERIMENT OBSERVATION INFERENCE 
I Test for Acid Radicals   
1. Test For Sulphate: 
2 ml of the above prepared 
extract is taken in a test tube to 
this add 2ml of 4%  
ammonium oxalate solution 
 
Cloudy appearance is 
not present 
 
Absence of sulphate. 
 
2. Test For Chloride: 
2 ml of the above prepared 
extract is added with dil. 
HNO3 till the effervescence 
ceases. Then 2ml of silver 
nitrate solution is added 
 
No cloudy appearance 
 
Absence or Chloride 
3. Test for Phosphate: 
2ml of the extract is treated 
with 2ml of ammonium 
molybdate solution and 2ml of 
Con. HNO3 
 
No cloudy yellow 
appearance 
 
Absence of Phosphate 
4. Test for Carbonate: 
2ml of the extract is treated 
with 2ml of magnesium 
sulphate solution 
 
No cloudy appearance 
 
Absence of Carbonate 
5. Test for Nitrate: 
1gm of the substance is heated 





Absence of Nitriate 
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concentrated H2SO4 and 
viewed the test tube vertically 
down 
6. Test for Suphide 
1 gm of the substance is 
treated with 2ml of Con. HCl 
 
Colourless no rotten 
egg smelling gas 
 
Absence of sulphide 
7. Test for Fluoride & Oxalate: 
2ml of extract is added with 
2ml of dil acetic acid and 2ml 
of calcium chloride solution 
and heated 
 
No cloudy appearance 
 
Absence of fluoride and 
oxalate 
8. Test for Nitrite: 
3 drops of the extract is placed 
on a filter paper on that 2 drops 
of acetic acid and 2 drops of 




Absence of Nitrite 
9. Test for Borate: 
2 pinches of the substance is 
made into paste by using 
sulphuric acid and alcohol 
(95%) and introduced into the 
blue flame 
 
Bluish green colour 
flame is not appeared 
 








II Test for Basic Radicals   
1. Test for Lead 
2ml of the extract is added with 






Absence of lead 
2. Test for Copper 
a. one pinch of substance is 
made into paste with con. 
HCl in a watch glass and 
introduced into the non-
luminous part of the 
Bunsen flame. 
b. 2ml of extract is added 
with excess of ammonia 
solution 
 






Appears  blue flame 
 






Presence of copper 
3. Test for Aluminum: 
To the 2ml of the extract 
sodium hydroxide is added in 





Absence of aluminum 
4. Test for Iron 
a. To the 2ml of extract add 
2ml of Ammonium 
Thiocyanate solution 
b. To the 2ml of extract add 
2ml of ammonium 
thiocynate solution and 
2ml of con HNO3 is added 
 
 












Absence of Iron 
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6. Test for Calcium: 
  2ml of the extract is added with 




white precipitate  is 
obtained 
 
Presence of Calcium 
7. 
 
Test For Magnesium: 
To 2ml extract sodium hydroxide 
solution is added in drops to 
excess 
 





8. Test For Ammonium: 
To 2ml of extract few ml of  
Nessler’s reagent and excess of  
sodium hydroxide solution are 
added 
 
Mild brown colour is 
reddish not appeared 
 
Absence of ammonium 
 
9. Test For Potassium: 
A pinch of substance is treated 
with 2ml of sodium nitrate 
solution and then treated with of 
cobalt nitrate in 30%  glacial 
acetic acid  
 
Yellow precipitate is 
not obtained  
 




10. Test For Sodium: 
2 Pinches of the substance is 
made into paste by using HCl and 
introduced in to the blue flame of 
Bunsen burner 
 
Yellow colour flame 
not appeared  
 
Absence of Sodium  
 
 
5. Test for Zinc 
To 2ml of the extract sodium 
hydroxide solution is added in 





Presence of Zinc 
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11. Test For Mercury: 
2ml of the extract is treated with 






Absence of Mercury  
12. Test For Arsenic: 
2ml of the extract is treated with 
2ml of silver nitrate solution 
 




Absence of Arsenic 
 
III Miscellaneous:   
1. Test For Starch: 
2ml of extract is treated with weak 
Iodine solution 
 
No blue color 
developed 
 
Absence of Starch 
2. Test for Reducing Sugar: 
5ml of Benedicts qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boil it for 2 minutes. 





Presence of Reducing 
Sugar 
3. Test for the Alkaloids: 
a. 2ml of the extract is 
treated with 2ml of 
Potassium Iodide solution. 
b. 2ml of extract is treated 
with 2ml of picric acid. 
c. 2ml of the extract is 
















Presence of alkaloid  
 
Presence of alkaloid 
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4. Test for Tannic Acid: 
2ml of extract is treated with 2ml 
of ferric chloride solution 
 
Black precipitate is 
obtained 
 
Presence of Tannic 
Acid 
5. Test for Unsaturated 
Compounds: 
To the 2ml of extract 2ml of 




permanganate is not 
decolorized 
 
Absence of unsaturated 
compound 
 
6. Test for Amino Acid: 
2 drops of the extract is placed on 
filter paper and dried well 
 
Violet colour not 
obtained 
 
Absence of amino acid 
7. Test for Albumin: 
2ml of the extract is added with 
2ml of ESBOCH’s reagent 
 
Yellow colour not 
precipitate is formed 
 
Absence of Albumin 
8. Test For Type of Compound: 
2 ml of the extract is treated with 
2 ml of ferric chloride solution 
 
No green colour 
developed 
 
No red colour 
developed 
 












amino acids and 














LOSS OF DRYING 
6 gms of materials is heated in a hot oven at 105oC to constant weight. The percentage of 
loss of weight was calculated. 
DETERMINATION OF ASH VALUE 
 Weigh accurately 2-3 gms of sample is tarred platinum of silica dish and incinerate at a 
temperature not exceeding 550oC until free from carbon cool and weigh. Calculate the 
percentage of ash with reference to the air dried drug.  
ACID INSOLUBLE ASH 
 Boil the ash for 5 minutes with 25ml of 1:1 dilute HCl. Collected the insoluble matter is 
Gooch – crucible on an ash less filter paper wash with hot water and ignite cool and weigh. 
Calculate the percentage of acid insoluble ash with reference to the air dried drug. 
WATER SOLUBLE ASH 
 To the Gooch crucible containing the total ash and 25ml of water and boil for 5 minutes. 
Collect the insoluble matter in a sintered glass crucible or on ash less filter paper. Wash with hot 
water and ignite in a crucible for 15 minutes at a temperature not exceeding 450oC. Subtract the 
weight of the insoluble matter from the weight of the ash; the difference of weight represents the 
water soluble ash. Calculate the percentage of water soluble ash reference to the air dried drug. 
ALKALINITY OF WATER SOLUBLE ASH 
 5gms converted to ash boiled with water filtered filtrate was titrated against 0.1 N of HCl 
using phenolphthalein as an indicator. 
 Alkalinity of water soluble ash = X x of acid / 0.1 x W. 
 X = Titre value 
 W = Weight of the materials taken 
 Alkalinity is given as ml of 0.1 N of HCl equal to 1 gm 
pH AT 10%  AQUEOUS SOLUTIONS 
 5 gms of Deepalinga chenduram is weighed accurately and placed in clear 100 ml 
beaker. A few drops of aquaregia was added and evaporated by heating for few minutes. After 
cooling the content 50 ml of distilled water is added to it and dissolved well. Wait for 30 minutes 





To determine the metals and minerals in  Deepalinga chenduram. 
INSTRUMENT 
 Atomic Absorption Spectrometer with Air – acetylene. 
APPARATUS AND EQUIPMENT 
 500 ml glass beakers hot plate watch glass 100 ml standard flask. 
CHEMICALS 
 Nitric acid hydrochloric acid certified reference standards. 
SAMPLE PREPARATION 
 Transfer a weighted sample in to a 50ml beaker. Add 10ml of 1 + 1 HNO3 and 10 ml of 
1+1 HCl and heat on a hot plate until the sample gets dissolved. Cool and filter to remove 
insoluble material. Transfer sample to 100 ml volumetric flask adjust volume to 100 ml and mix. 
Take all precautions to avoid contamination at all stages. Prepare a reagent blank containing 
same amounts of acids used in the preparation of sample Aspirate the standards and sample into 
AAS instrument as per instrument procedure. 
CALCULATION 
 Percentage of the element = A / B x 100 
 A:  Concentration of sample in ppm 
 B:  Dilution factor 















ACUTE TOXICITY STUDIES OF DEEPA LINGA CHENDURAM 
ANIMALS AND METHOD OF DRUG TREATMENT 
 Healthy albino mice of either sex weighing around 22-28 g and overnight- fasted were 
used for study. Food was withdrawn during the study however free access to water was provided. 
The weighed animals were randomly assigned to seven groups of six animals each (n=6) and 
were administered the Deepalinga chendooam orally in the increasing doses 100 500 1000 2000 
and 4000 mg/kg. Honey was used as vehicle. Starting dose was 100mg/kg. Deepa Linga 
Chenduram suspended in honey was administered to the groups of wistar rats in a single oral 
dose by gavage using a feeding needle. The control group received an equal volume of the honey 
vehicle. Three females and males were used for each dosage level. Observations were made and 
recorded systematically during 24h after substance administration. The visual observations 
included skin changes mobility aggressiveness sensitivity to sound and pain as well as 
respiratory movements. They were deprived of food but not water 16–18 h prior to the 
administration of the test suspension. Finally the number of survivors was noted after 24 h and 
these animals. The toxicological effect was assessed on the basis of mortality.  
ANTI-INFLAMMATORY ACTIVITY OF DEEPALINGA CHENDURAM 
IN RATS 
MATERIALS AND METHODS 
 Wistar strain rats of either sex weighing between 120-150 g were used. They were kept 
on standardised diet and water ad libitum. Suspensions of the Deepalinga chenduram with honey 
were prepared and used. Acute inflammation was produced by sub plantar injection of 0.1 ml of 
2%  suspension of formalin in normal saline in the right hind paw of the rats. Paw volume was 
measured plethysmometrically during 0-2 hours after irritant injection. The animals were treated 
with appropriate dose of Deepalinga chenduram in honey (400 mg/kg. orally) Honey (3ml/kg 
orally) treated animals served as control and acetyl salicylic acid (150 mg/kg orally) was 
administered as standard drug. Mean increase in paw volume was measured and percentage of 
inhibition was calculated. Statistical analysis was done by unpaired Student's ' t ' test. P values 
<0.05 were considered significant.  
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EVALUATION OF ANTIHISTAMINIC ACTIVITY OF DEEPALINGA 
CHENDURAM 
INTRODUCTION 
 Antihistaminics are used in symptomatic treatment of rhinitis sneezing rhinorrhoea basal 
itch etc. However many of them produce drowsiness and CNS depression. The drug Deepalinga 
chenduram has been indicated for Karappan. It is believed that this drug will have good action 
against eczema. And also shown promising antiallergic activity in cases of rhinitis and is found 
to be devoid of side effects. This observation prompted us to evaluate the antihistamine effect of 
Deepalinga chenduram in guinea pig ileum preparation. The histamine wheal test was performed 
on the dorsal area of guinea pig by injecting 2 µg of histamine phosphate in 0.1 ml of distilled 
water by the intra dermal route the erythema and wheal were observed 15 min after the injection 
and noted by outlining the margins. The same dose was applied in in vitro method also.  The 
findings were comparable to those of invitro results. A single dose of Deepalinga chenduram 
showed significant antihistaminic activity which distinguished it from conventional 
antihistaminics. The mechanism of action needs further investigation.  
PREPARATION OF GUINEA PIG ILEAL STRIP 
 Briefly the abdomen was cut open and the small intestine segment of the ileum (4 cm 
long) was removed 10 cm from the caecum and cleaned and suspended in a 20 ml organ bath 
containing Tyrode solution (composition mmol/L; NaCI 136.0; KCI 2.7; CaC12 1.8; MgCl2 1 .O; 
NaH2PO4 0.3; glucose 5.5 and NaH2CO3 12.0) maintained at 37°C and gassed with air. The 
preparation was allowed to equilibrate under a resting tension of 0.5g for 30 min during which 
the Tyrode solution was changed at 20 min intervals. Isotonic contractions with Magnification x 
7 were recorded on a smoked paper through a frontal writing lever. The dose response curve of 
histamine was recorded and the 0.1ml of Deepalinga chenduram 1mg/ml solution was added to 
the tissue organ bath and irrigated for 30minutes. Then the three middle dosed responses of 
histamine was recorded in the presence of Deepalinga chenduram.  In the above experiment the 
pH of the Deepalinga chenduram before adding to the organ bath and when in the bath was 
measured. Contact time of Deepalinga chenduram or standard agonist with the tissue was 
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 fj;jhp> jf;fhsp> Kl;il> Nfhop> nkhr;ir> gPHf;fq;fha;> Glyq;fha; cztpy; 
jtpHf;fTk;. 
 cg;G ePhpy; Fspg;gij jtpHf;fTk; 
 jpdKk; ,UKiw Fspf;fTk;. 
 nfhOg;Grj;J kpf;f czTfis cl;nfhs;sTk;. 




 gUj;jp tif cilfis mzpaTk; 
 Njhy; nghUshy; Md nrUg;G ifg;ig cgNahfpg;gij jtpHf;fTk;. 
 kd cisr;riy Fiwf;f> jpahdk; kw;Wk; Nahfg;gapw;rpfis  
Nkw;fnfhs;sTk;. 
 mfj;jp> ghfy;> Nfhop> kUe;Jz;Zk; fhyj;jpy; jtpHf;fTk;. 
 Gspg;G> cg;G> RitAs;s cztfis Fiwj;J (m) ePf;fp cz;zTk;. 






























Eczema is non contagious inflammation of the skin characterized by 
erythemascalingoedemavesiculation and oozing. 
            Eczema or dermatitis is a reaction pattern that presents with variable clinical and 
histologic findings. Primary lesions may include papules  erythematous macules and vesicles  
which can coalesce to form patches and plaques. In severe eczema secondary lesions from 
infection or excoriation marked by weeping and crusting may predominate. Long standing 
dermatitis is often dry and is characterized by thickened scaling skin (lichenification) 
CAUSES 
• Irritants-Physicalchemical or electrical. 
• Sensitizers-Plantscosmeticsclothingmedicamentsand occupational hazards. 
• Exernal infections-Streptococcistaphylococcifungus etc 
• Mental and emotional conflictsstrains and stresses. 
• Internal septic focus shedding toxins or causing bacteremia 
• Diet and state of digestion 
• Diathesis-allergicxerodermichyperhydrotic or seborrhoeic 
• Drugs-given for the disease or otherwise. 
• State of local or general nutrition. 
• Climate – temperature and humidity. 
TYPES 
• Photo dermatitis 
• Contact dermatitis 
• Infective eczematoid dermatitis 
• Endogenous eczema 
• Infantile eczema 
• Seborrhoeic eczema 
• Atopic eczema 
• Discoid eczema 
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• Disseminated eczema 
• Varicose eczema 
• Radio dermatitis 
• Occupational and industrial dermatitis  
ATOPIC DERMATITIS 
                 Atopic dermatitis is the cutaneous expression of the atopic state characterized by a 
family history of asthma hay fever or dermatitis in up to 70  %  of patients. 
                 The etiology of atopic dermatitis is only partially defined but there is a clear genetic 
predeisposition. When both parents are affected by atopic dermatitis. 
Over 80% of their children manifest the disease. When only one parent is affected  the 
prevalence drops to slightly over 50%  
 
CONTACT DERMATITIS 
 Contact dermatitis is an inflammatory process in skin caused by an exogenous agent or 
agents that directly or indirectly injure the skin This injury may be caused by an inherent 
characteristic of a compound –irritant contact dermatitis (ICD). An examplef (ICD) would be 
dermatitis induced by a concentrated acid or base . 
 Agents that cause allergic contact dermatitis (ACD) induce an antigen –specific 
immune response. 
 
HAND ECZEMA  
                Hand eczema is a very common chronic skin disorder. It represents a large proportion 
of occupation associated skin diseases.Similar to other forms of dermatitis both exogenous and 
endogenous factors play important roles in expression of hand dermatitis. 
 
NUMMULAR ECZEMA  
               Nummular eczema is characterized by circular or oval coinlike lesions. Initially this 
eruption consists of small edematous papules that become crusted and scaly.The most common 
locations are on the trunk or the extensor surfaces of the extremitiesparticularly on the pretibial 






               Asteatotic eczema also known as xerotic eczema or winter itch is a mildly 
inflammatory dermatitis that develops areas of extremely dry skin especially during the dry 
winter months. 
STASIS DERMATITIS AND STASIS ULCERATION  
               Stasis dermatitis develops in the lower extremities secondary to venous incompetence 
and chronic edema .Early findings in stasis dermatitis consists of mild erythema and scaling 
associated with pruritis .The typical initial site of involvement is the medial aspect of the ankle 
often over a distended vein 
SEBORRHOEIC DERMATITIS 
                         Seborrhoeic dermatitis is a common chronic disorder characterized by greasy 
scales overlying erythematous patches or plaques.The most common location is in the scalp 
where it may be recognized as severe dandruff. On the face seborrhoeic dermatitis. Affects the 
eyebrows eyelids glabella and nasolabial folds.Scaling of the external auditory canal is common 
in seborrhoeic dermatitis and may be mistaken for a fungi infection. Additionally seborrhoeic 


















 SELECTION OF PATIENTS 
 
 30 Patients (both sex) were selected from the out patient department of National Institute 
of SiddhaChennai-47exclusion of withdrawl criteria. 
 
CRITERIA FOR SELECTION 
    INCLUSION CRITERIA 
  Age group 15- 70 yrs of both sex. 
 Willing to attend the OPD once in 7 days for 48 days.  
     EXCLUSION CRITERIA 
 Diabetes  
 Renal diseases 
 Malignancy  
 Pregnancy 
 Lactation 
 Liver disorders 
 Connective tissue disorder  
     WITHDRAWL CRITERIA 
 The drug intolerance 
 Any acute illness during the trial period 
LINE OF TREATMENT 
 The drug Deepalinga chenduram was administered internally in a dose of 65mg two 
times with honey after food for 48 days.  
DIET RESTRICTION  

















All collected data were entered into computer using MS excel program and analysed 
using STATA software. The improvement shown after treatment in terms of clinical symptoms 
viz Itching, oozing, hyperpigmentation, papules, erythema, swelling and scales 











 OBSERVATION  
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RESULTS AND OBSERVATIONS 







1                               Reducing sugar  Present 
2                               Tannic acid  Present 
3                               Magnesium Present 
4                               Copper Present 
5                               Zinc Present 
6                              Calcium Present 
 
  Table - 2    PHYSICAL PROPERTIES 
 
Sl. No.  
             Parameter 
 
Results (% ) 
1.             Loss of drying @105oC 0.18 
2.             Ash value 2.56 
3.             Acid insoluble ash 1.24 
4.             Water soluble 4.67 
5.             PH
 
 at 10%  aqueous solutions 5.14 
6.             Alkalinity as CaCo3 in water soluble Ash 0.11 
 







1.                              Magnesium 796 mg/kg 
2.                              Copper 17.4 mg/kg 
3.                              Zinc 50.0 mg/kg 




ACUTE TOXICITY STUDY OF “DEEPALINGA CHENDURAM” 
 
 The animals showed minor changes in general behavior or other physiological activities. 
The symptoms like continuous grooming tremor at high dose range sedation in the entire group 
after drug treatment diarrhoea (30th min) was generally observed in the above 2000mg/kg-dosed 
animals. No death was recorded during the treatment period in treated groups given 2-4g/kg of 
Deepalinga chenduram orally. So it can be concluded that a test substance is practically non-






 Table-4 INCREMENTAL DOSE FINDING EXPERIMENT AND ITS SIGNS OF TOXICITY OF “DEEPALINGA CHENDURAM” 
No Treatment Dose mg/ml/kg 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. I 100 + - - + + + - - - - - - - - - - - - - - 
2 II 250 + - - + + + - + - - - - - - - - - - - - 
3 III 500 + - - + - + - + - - - - - - - - - - - - 
4 IV 1000 + - - + - + - + - - - - + - - - - - - - 
5 V 1500 + - - + - + - + - - - - + - - - - - - - 
6 VI 2000 + - - + - + + + - - - - + - - - - - - - 
7 VII 4000 + - - + - + - + - - - - + - - - + - - - 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming 5. Gripping 6. Touch Response 7. Increased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. Catatonia 12. 
Muscle relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Number of Deaths (Mortality) 
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ANTI INFLAMMATORY ACTIVITY OF DEEPALINGA CHENDURAM 
The results of the present investigation suggest that Deepalinga chenduram  have significant 
anti-inflammatory effect against formalin induced paw oedema in rats. In formalin induced paw 
oedema the effect of Deepalinga chenduram was more than that of acetylsalicylic acid. Formalin 
induced paw oedema is the standard experimental model of acute in flammation. In the present 
investigation as the test drug is effective in the model of inflammation there is a possibility that 
this drug may be effective in acute inflammation.  
   
  Table-5    Effect Of Deepalinga Chenduram (DLC) and Aspirin On Formalin Induced Rat 
Paw Oedema. 
S.no Treatment Dose (mg/kg) Mean increase in paw 
volume (ml) 
Percentage inhibition 
in paw volume 
1 Control (Honey) 2ml/kg 0.668±0.048 - 
2 
Acetyl salicylic acid 
150 0.249±0.081** 62.72 
3 DLC 400 0.367±0.039* 45.05 
 
Values are mean + SEM; n=6 animals in each group. *P <0.05; **P <0.01 when compared to 
control 
                                 
0 . 6 6 8 0 0 . 2 4 9
6 2 . 7 2
0 . 3 6 7









Contr ol  (Honey)  /  2ml  /  kg A cetyl  sal i cy l i c aci d  /  150 DLC /  400
PHARMACOLOGICAL STUDY




ANTI–HISTAMINIC ACTIVITY OF DEEPALINGA CHENDURAM 
 
 The results of this study may suggest the following. First the Deepalinga chenduram may 
contain 5-HT like substances. Second the Deepalinga chenduram may cause the release of 5-HT 
from the tissue. If the second possibility is considered then it may explain the relatively delayed 
onset of action of the Deepalinga chenduram The nature of antagonism of the Deepalinga 
chenduram may be competitive as there is a progressive shifting of the dose- response curve to 






CLINICAL ASSESSMENT  
For the clinical study of Deepalinga chenduram in Karappan 30 patients were selected. 
 
Table-6   Age distribution 
Age Female Male 
15-30yrs 16.67 16.67 
31-40 yrs 23.3 10 
41-50 yrs 16.67 0 
51-60 yrs 6.67 10 
 
 











According to  age distribution in less than 31 yrs 16.67% female and 16.67% male were in 15- 
31 yrs. 23.3%  female and 10%  male were in 31- 40 yrs 16.67% female were in 41-50 yrs 6.67%  







Table-7 Symptoms and signs  
Symptoms Before treatment(% ) After Treatment(% ) Improved(% ) 
Itching 100 10 90 
Oozing 86.6 3.8 96.15 
Hyper 
Pigmentation 100 93.3 6.6 
Papules 100 3.3 96.7 
Erythema 26.67 0 100 
Swelling 13.3 0 100 
Scales 86.7 0 100 
 
From clinical assessment 90 %  of patients get relieved from itching 96.15 %  of patients get 
relieved from oozing 6.6%  of patients get relieved from hyperpigmentation 96.7%  of patients 
get relieved from papules 100%   of patients get relieved from erythema  100%  of patients get 

































Papules Erythema Swelling Scales
Before treatment After Treatment Improved
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 Drug  Deepalinga chendooram  Dose – 65mg b.d with honeyDiagnosis  -  Karappan Noof   Days treated  -  48 Days 
SLNO NAME A/S OP.NO IG IG OG OG HPN HPN PS PS EA EA SG SG SS SS 
        BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 MeeraBai 60/F AG2521 + - + - + + + - + - + - + - 
2 Rajendran 59/M AG5408 + - + - + + + - - - - - + - 
3 Rajasekaran 49/M AG5471 + - + - + + + - + - - - + - 
4 SurendraBabu 57/M AG5683 + - + - + + + - + - - - + - 
5 Veerabathran 60/M AG5854 + - + - + + + - + - - - + - 
6 Kalaiarasi 25/F AG5893 + + + + + + + + + - + - + - 
7 Sundari 40/F AG5927 + - + - + + + - - - - - + - 
8 KalayaPerumal 60/M AG1280 + - + - + + + - - - - - + - 
9 Vijaya 55/F AG6237 + - + - + + + - + - + - + - 
10 Mythili 40/F AG6184 + - + - + + + - - - - - - - 
11 Indira 32/F AG6234 + - + - + + + - - - - - + - 
12 Britto AmalRaj 48/M AG6390 + - - - + + + - - - - - + - 
13 Manoharan 66/M AG6669 + - + - + + + - - - - - + - 
14 Duraisingh 60/M AG6544 + - - - + + + - - - - - + - 
15 Kasturi 59/F AG6541 + - + - + + + - - - - - + - 
16 Ethirajan 56/M AG7066 + - + - + + + - - - - - - - 
17 Lakshmi  30/F AG7023 + + - - + + + - - - - - + - 
18 Jayaraman 60/M AG8041 + - + - + + + - - - - - + - 
19 Shanti 42/F AG8112 + - + - + + + - - - - - + - 
20 Jayaraman 60/M AG7363 + - + - + + + - - - - - + - 
21 Sumithra 19/F AG7244 + + - - + + + - - - - - + - 
22 Velayudham 52/M AG2638 + - + - + - + - - - - - + - 
23 Baskar 28/M AG6737 + - + - + + + - - - - - + - 
24 Chinnakannan 43/M AG8779 + - + - + + + - - - - - - - 
25 Ranganathan 44/M AG7016 + - + - + + + - + - + - + - 
26 Anbu selvam 43/M AG8159 + - + - + + + - - - - - + - 
27 Kamaraj 60/M AG8152 + - + - + + + - - - - - + - 
28 Jahir 38/M AG7678 + - + - + + + - - - - - + - 
29 Meena 58/F AG6288 + - + - + + + - - - - - - - 
30 Selvaraj 55/M AG7083 + - + - + - + - + - - - + - 
                  
 
IG  -   Itching 
 
HPN -   Hyperpigmentation EA -  Erythema 
   
SS  -  Scales 
 
 
OG -   Oozing 
 
PS -  Papules 
  
SG -  Swelling 
        
 SIZE OF LESION(cms) 
 
S.no Right Left 
 Length Breadth Length 
 
Breadth 
 BT AT BT AT BT AT BT AT 
1.  20 18 10 9 23 19 18 17 
2.  10 9 5 4 18 16 20 18 
3.  10 9 5 4 9 8 8 8 
4.  8 7 10 8 5 5 4 4 
5.  15 14 3 2 12 11 3 2 
6.  7 7 3 3 6 6 2 2 
7.  23 20 10 8 10 8 8 7 
8.  8 7 2 1 10 9 3 2 
9.  10 9 8 7 11 10 7 5 
10.  10 9 3 2 8 6 4 3 
11.  10 9 5 4 12 11 5 5 
12.  35 33 15 13 40 38 15 14 
13.  25 24 5 4 18 16 4 3 
14.  - - - - 10 8 3 2 
15.  19 18 15 14 16 14 14 12 
16.  10 8 4 4 13 12 4 4 
17.  8 7 3 3 - - - - 
18.  20 18 18 16 8 7 10 9 
19.  25 23 17 15 17 16 12 9 
20.  10 9 3 2 - - - - 
21.  10 10 7 7 12 12 8 8 
22.  7 5 5 4 - - - - 
23.  21 19 15 13 - - - - 
24.  12 10 7 6 7 6 3 2 
25.  15 12 8 6 10 9 5 3 
26.  - - - - 10 9 7 6 
27.  - - - - 10 9 8 6 
28.  - - - - 5 4 2 1 
29.  11 10 2 2 9 9 2 2 
30.  8 6 3 2 14 12 3 2 
 
 LAB INVESTIGATION AT THE TIME OF TREATMENT 
S.NO NAME A/S OPNO BLOOD URINE MOTIO
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       P L E M ½ hr 1 hr        PC EC   
BT 12.8 7500 52 45 3 - 11 22 3.8 144 22 0.7 0.7 - - 1-2 1-2 - - 
21st  - - - - - - - - - - 22 0.7 - - - 1-2 1-2 - - 
1. Meera bai 65/F AG2521 
AT 12.7 7000 50 48 2 - 4 8 3.8 150 20 0.8 - - - 2-3 2-3 - - 
BT 13.6 7200 50 46 4 - 5 12 0.9 120 19 0.5 0.9 - - 1-2 1-2 - - 
21S - - - - - - - - - 141 21 0.8 - - - 1-2 1-2 - - 
2. Rajendaran 59/M AG5408 
AT 13.8 7100 52 40 2 6 5 10 0.7 130 20 0.7 - - - 2-3 2-3 - - 
BT 12.1 7100 50 48 2 - 3 7 0.7 128 31 0.8 0.8 - - 2-3 2-3 - - 
21S - - - - - - - - - - 30 0.8 - - - 1-2 2-3 - - 
3. Rajasekaran 49/M AG5471 
AT 12.0 7000 50 49 1 - 2 4 - 130 30 0.7 - - - 2-3 1-3 - - 
BT 15.1 8000 56 42 2 - 5 10 4.6 89 16 0.6 0.7 - - 2-3 1-2 - - 
21S - - - - - - - - - - 20 0.7 - - - 2-3 1-2 - - 
4. Surendrababu 57/M AG5683 
AT 15.0 7500 54 44 2 - 2 4 4.5 100 18 0.7 - - - 1-2 1-2 - - 
BT 12.3 8100 52 42 2 4 8 10 0.7 130 18 0.8 0.7 - - 1-2 1-2 - - 
21S - - - - - - - - - - 20 0.7 - - - 1-2 1-2 - - 
5. Veerapatran 60/M AG5854 
AT 12.2 8000 54 44 2 - 2 4 3.8 100 19 0.7 - - - 2-3 1-2 - - 
BT 12.1 7800 58 40 2 - 16 32 3.9 128 19 0.8 0.7 - - 1-2 2-3 - - 
21S - - - - - - - - - - 18 0.9 - - - 1-2 1-2 - - 
6. Kaliarasi 25/F AG5893 
AT 12.0 8000 52 46 2 - 10 20 3.9 130 18 0.8 - - - 1-2 1-2 - - 
BT 13.0 8500 56 40 4 - 8 16 4.2 110 20 0.8 0.7 - - 1-2 2-3 - - 
21S - - - - - - - - - - 21 0.9 - - - 1-2 2-3 - - 
7. Sundari 40/F AG5927 







LAB INVESTIGATION AT THE TIME OF TREATMENT 
S. 
NO 
NAME A/S OPNO BLOOD URINE MOTI
ON 
 





























































































































































       P L E M ½ hr 1 hr        PC EC   
BT 13.8 7500 52 44 4 - 16 32 4.3 100 20 0.7 0.7 - - 2-4 1-2 - - 






AT 13.5 8000 50 48 2 - 8 16 4.3 110 20 0.8  - - 1-2 1-2 - - 
BT 10.7 8000 55 39 6 - 30 62  85 20 0.9 0.9 - - 1-2 2-3 - - 









AT 10.5 8100 50 48 2 - 10 20  95 21 0.8  - - 1-2 1-2 - - 
BT 12.1 6100 50 48 2 - 5 11 4.0 80 15 0.7 0.8 - - 2-3 2-3 - - 









AT 12.0 7500 50 48 2 - 2 4 4.1 90 18 0.7  - - 1-2 2-3 - - 
BT 10.2 6000 50 48 21 - 6 15 3.4 95 21 0.7 0.9 - - 3-4 1-2 - - 









AT 10.5 7000 50 48 2 - 2 4 3.2 110 22 0.7  - - 1-2 1-2 - - 
BT 13.1 6800 52 47 1 - 6 12 4.3 151 15 0.8 0.7 - - 3-4 - - - 
21S - - - - - - - - - - 16 0.3    2-3 1-2 - - 
12. Brittomaraj 48/M AG6390 
AT 13.5 7000 50 48 2 - 2 4 4.5 149 16 0.7  - - 1-2 1-3 - - 
BT 13.5 8500 62 30 8 - 2 16 4.0 100 20 0.7 0.7 - - 2-3 1-2 - - 












 AT 13.0 8000 50 48 2 - 2 4 4.0 110 21 0.7  - - 1-2 1-3 - - 
BT 13.1 8600 54 44 2 - 5 10 4.2 121 35 0.7 0.8 - - 2-4 3-4 - - 















 LAB INVESTIGATION AT THE TIME OF TREATMENT 
S. 
NO 

































































































































































       P L E M ½ hr 1 hr        PC EC   
BT 11.1 9900 62 30 8 - 20 42 3.7 118 16 0.5 0.8 - - 2-3 3-5 - - 







AT 11.5 9800 55 44 1 - 8 16 3.8 120 18 0.6  - - 1-2 1-2 - - 
BT 11.7 5900 50 40 2 8 5 11 3.9 78 16 0.5 0.7 7 - 2-3 1-2 - - 
21S - - - - - - - - - 100 20 0.6  - - 1-2 1-2 - - 
16. Eththirajan 56/M AG7066 
AT 11.8 6000 50 48 2 - 2 4 4.0 141 18 0.7  7 - 1-2 1-2 - - 
BT 11.7 5900 55 44 1 8 5 10 0.7 100 15 0.8 0.7 - - 2-3 2-3 - - 












 AT 11.8 6000 50 40 2 - 2 4 3.9 80 20 0.7  - - - - - - 
BT 12.2 6700 51 44 3 - 6 12 4.1 130 23 0.7 0.78 - - 4-6 2-4 - - 









AT 12.3 7000 50 48 2 - 3 6 4.0 120 20 0.7  - - 1-2 1-2 - - 
BT 12.0 5700 49 46 4 - 8 18 4.0 130 13 0.3 0.7 - - 1-2 2-3 - - 
21S - - - - - - - - - - 15 0.4  - - 1-2 2-3 - - 
19. Shanthi 42/F AG8112 
AT 12.5 6000 50 48 2 - 4 8 4.0 150 15 0.4  - - 1-2 1-2 - - 
BT 12.5 8500 56 40 4 - 8 6 3.8 100 18 0.7 0.7 - - 2-4 1-2 - - 









AT 12.6 9000 50 48 2 - 2 4 3.9 110 20 0.7  - - 1-2 1-2 - - 
BT 12.5 7500 56 40 4 - 8 16 4.2 140 18 0.7 0.6 - - 2-4 1-2 - - 
21S - - - - - - - - - - 18 0.7  - - 1-2 1-2 - - 
21. Sunithra 19/F AG7244 

















NAME A/S OPNO BLOOD URINE MOTION 






























































































































































       P L E M ½ hr 1 
hr 
       PC EC   
BT 13.1 9600 53 40 5 2 5 11 0.7 100 20 0.8 0.8 - - 2-4 2-4 - - 







AT 13.0 9500 50 48 2 - 2 4 0.7 120 18 0.6  - - 1-2 1-2 - - 
BT 10.8 9200 60 32 8 - 5 11 3.5 95 20 0.7 0.6 - - 2-3 2-3 - - 
21S - - - - - - - - - - 19 0.6  - - 2-4 2-4 - - 
23. Baskar 28/F AG6737 
AT 11.0 9500 50 48 2 - 2 4 3.8 100 20 0.6  - - 1-2 1-2 - - 
BT 11.0 7500 50 47 3 - 6 12 2.5 97 17 0.5 0.8 8 - 3-4 2.3 - - 












 AT 11.0 8000 50 48 2 - 4 8 - 108 18 0.6  - - 1-2 1-2 - - 
BT 12.1 6400 52 46 2 - 2 5 4.0 112 18 0.8 0.7 - - 3-4 1-2 - - 
21S - - - - - - - - - - 16 0.8  - - 3-4 1-2 - - 
25. Ranganathan 44/M AG7016 
AT 12.2 7000 50 48 2 - 2 4 4.0 110 20 0.8  - - 1-2 1-2 - - 
BT 13.8 7800 62 34 4 - 16 32 4.2 94 21 0.8 0.69 - - 2-4 1-2 - - 







AT 13.8 8000 54 44 2 - 2 4 4.2 100 20 0.8  - - 1-2 1-2 - - 
BT 12.8 7800 62 36 2 1 8 16 3.8 98 16 0.5 0.7 - - 2-3 1-2 - - 
21S - - - - - - - - - - 17 0.6  - - 1-2 1-2 - - 
27. Kamaraj 60/M AG8152 
AT 12.5 8000 50 47 3 - 4 8 3.8 110 16 0.5  - - 2-3 1-2 - - 
BT 13.1 8000 52 44 3 1 4 8 0.7 76 16 0.8 0.7 - - 4-6 2-4 - - 












 AT 13.0 7500 50 48 2 - 2 4 4.2 100 18 0.7  - - 1-2 1-2 - - 
BT 9.7 5900 50 48 - 2 6 12 3.2 109 23 0.8 0.8 - - 3-5 2-3 - - 








AT 10.0 6000 50 40 2 8 2 4 3.3 120 25 0.7  - - 1-2 1-2 - - 
BT 9.8 5500 50 49 1 - 2 4 3.2 100 17 0.8 0.7 7 - 1-2 2-3 - - 
 - - - - - - - - - - 16 0.5  - - 2-3 1-2 - - 
30. Selvaraj 55/M AG7083 

























The following studies are confirmed the efficacy of Deepalinga Chenduram in 
management  of  Karappan(Eczema) 
 
The literary evidence from Siddha Collection strongly support that Lingam has a best 
effect in treatment  of Karappan(Eczema) 
            
Bio-Chemical analysis of the drug Deepalinga Chenduram reveals the presence of Zinc 
Calcium Magnesumreducing sugar  and Tannic Acid. 
 
ZINC 
Zinc helps in the function of enzymes superoxide dimutase (SOD) which an anti-oxidant. 
Thus it cures eczema by scavenging free radicals. 
 
CALCIUM 
Calcium is essential to the health of the skin a lack of which will cause welts eczema and 
soles cracks in the skin calcium lactable  a salt of calcium helps in preventing eczema. 
 
MAGNESIUM 
Magnesium is necessary for calcium and vitamin C metabolism when combined with 
calcium acts as a natural tranquilizer. It is called as anti-stress mineral. It improves the blood 
circulation and keeps the skin healthy and glowing.  
One of the cause of eczema is “mental stress”. Magnesium gives relief from mental stress. Thus 
it cures eczema. 
 
TANNIC ACID 
The properties of Tannic Acid is anti-bacterial anti-dermatotic anti septic and anti-ulcer 








               The pharmacological action of the drug Deepalinga Chenduram was carried out in 
Vel’s college of PharmacyPallavaramChennai. 
 
              Antiinflammatory activity in rat models using Wistar albino ratscarried out in 2% 
Formalin induced paw edema .The study gives satisfactory antiinflammatory result. 
         
  Antihistamine activity conducted in Guinea pigs ileum  carried out by histamine 
phosphate induced hitamine activity.The study gives satisfactory antihistamine 
result. 
 
              Both pharmacological actions are effective at the dose of 400mg/kg  
 
Clinical study 
            For the clinical study of Deepalinga chenduram in Karappan30 patients were selected 
According to age distribution in less than 31 yrs 16.67% female and 16.67% male were in 15- 31 
yrs. 23.3%  female and 10%  male were in 31- 40 yrs 16.67% female were in 41-50 yrs 6.67%  
female and 10%  male were in 51-60yrs. 
 
  From clinical assessment 90 %  of patients get relieved from itching 96.15 %  of patients 
get relieved from oozing 6.6%  of patients get relieved from hyperpigmentation 96.7%  of 
patients get relieved from papules 100%   of patients get relieved from erythema  100%  of 
patients get relieved from swelling 100%  of patients get relieved. 
 
  From the clinical and statistical analysis  it is proved that the drug Deepalinga 
chenduramis statistically significant (84.20%) 
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From the above text it is understood that Kaippu Karuppu Suvaigal neutralize the 
Kapa kutram so the selected drug acts well in Karappan  
 
‘NgjpRuQ; re;jp ngUtpuz ePnuhLj1 
fhjfb fhrq; fug;ghd;Gz;-Nzhj 
TUtpypq;f rq;fjkh A+Wfl;b Ak;Nghq; 
FUtpypq;f rq;fkj;ijf; nfhs;.” 
!
 From the above the text it is understood that Lingam has best effect in curing Karappan 
disease. 
 
All the above studies showed that Deepalinga chenduram was efficacious in Mangement 





















               The drug Deepalinga Chenduram has taken for the study to evaluate its efficacy in  the 
management of  Karappan (Eczema). 
 
               The literary evidence from Siddha Collection strongly support that Lingam has a best 
effect in treatment  of Karappan(Eczema) 
 
    Bio-Chemical analysis of the drug Deepalinga Chenduram reveals the presence of Zinc 
Calcium Magnesumreducing sugar  and Tannic Acid. 
 
               Pharmacological studies showed that the drug has significant anti-inflammatory and 
antihistamine activity at the dose of 400mg/kg bw non-significant adverse effects. 
 





                From the pharmacological studies and clinical study concluded that the drug 
Deepalinga Chenduram has significant anti-inflammatory and antihistamine activity . 
 















AN OPEN CLINICAL TRIAL OF SIDDHA DRUG NELLI VATRAL 
CHOORANAM FOR THE TREATMENT OF  PEENISM (SINUSITIS) 
     -A PILOT STUDY 
FORM I-SELECTION PERFORMA 
 
1. OP/IP No:_________________              2.BED No:_______3.S.No:_______________ 
 
4. NAME:__________________________5.AGE:_______ 6.GENER:____________ 
 
7. DATE OF ADMISSION TO THE TRIAL 
 
8. OCCUPATION: ________________________ 
 




                                       ______________________________________ 
 
10. COMPLAINS & DURATION: 





11. HISTORY OF PRESENT ILLNESS: 






12. PAST HISTORY: 
                …………………………………………………………………………………… 
……………………………………………………………………………………………… 
 
13. FAMILY HISTORY: 
               ……………………………………………………………………………………. 
……………………………………………………………………………………………… 
 
14. MENSTRUAL HISTORY: Regular Irregular                  Not applicable  
 
 





15. SOCIAL HISTORY: 
     Low socio economic  Middle class  Higher class  
 
16.HABITS                                                                  YES (1)           NO (2) 
                                                                      
i. Smoker    
                           
ii. Alcoholic  
iii. Betel Nut chewer              
 
iv. Drug Addiction   
              
 v.Non-vegetarian: 
  






 i.Weight (kg):                                                    
        
ii.Temperature (°F):         
  
iii.Pulse rate / minute:                                          
 
iv.Heart rate / minute:        
 
v.Respiratory rate / minute:                              
   
vi.Blood pressure (mmHg):                               /       / 
 
                                                      1. Yes                    2.No            
vii.Pallor:                                 
 
viii.Jaundice:                       
 
ix.Cyanosis:  
           
x.Lymphadenopathy:  
  
xi.Pedal oedema:  
  
xii.Clubbing                                
 
xiii.Jugular vein pulsation:            
 




xvi.Abdominal Distension  
 
 18.CLINICAL EXAMINATION 
    Yes                  No 
 
i. Sneezing  
 










vii.Tenderness in the frontal  
       region 
    
viii.Tenderness in the maxillary 
    region     
 
ix.Body pain 
   
x.Change in sense of smell 
 
 
19.EXAMINATION OF OTHER SYSTEMS 
 
 
                                               Normal         Affected 
 
i. CVS                                                                 
                                                                                                     __________________ 
       
ii. RS             
                                                       _                                            ________________ 
 
 iii. CNS                                                        __________________ 
  
iv.RENAL SYSTEM                         ________________ 
   
 
v..ENDOCRINE SYSTEM                                                     __ ______________ 
 
 vi.NERVOUS SYSTEM                                                 __________________ 
               
 
 vii..ABDOMEN:                                                                        __________________ 
 
  20.SIDDHA SYSTEM OF EXAMINATONS 
     THINAI 
      1. Kurunji           2. Mullai                3. Marutham     
 
      4. Neithal                5. Palai 
 
 i.PARUVA  KAALAM 
 
     1. Elavenil kalam         2.Muthuvenil kalam 
  
     3. Mazhai kalam             4. Kulir kalam  
  
   5. Munpani kalam             6. Pinpani kalam     
ii.YAKKAI 
  1. Vali                   2. Azhal           3. Iyam     
  
    4. Valiazhal       5. Valiaiyam           6. Azhalvali   
    
  7. Azhaliyam     8. Iyavali            9. Iyaazhal  
 iii.GUNAM 
    1. Sathuva gunam                  2. Rajo gunam         
 
    3. Tamo gunam                                        
 
iv.IYMPORIKAL        Normal            Affected                    
  
    Mei                    _____________________ 
 
   Vaai                                ______________________ 
 
  Kan                           _____________________ 
 
  Mookku                        _____________________ 
 
  Sevi                                           _____________________ 
 v. KANMENTHIRIUM  
  Kai               _____________________ 
 
 Kaal                _____________________ 
 
 Vaai                      _____________________ 
 
 Eruvai                    ____________________ 
 
 Karuvaai        ____________________ 
                                                                                                                                       
vi.UYIR THATHUKKAL Normal          Affected 
VALI    
Pranan                                                    ____________________ 
 
Abanan                                       _____________________ 
 
Samanan                                                    ____________________ 
                     
Udhanan                                        _____________________ 
 
Viyanan                                    _____________________ 
 
Nagan                                                    _____________________ 
 
Koorman                                                    ____________________ 
   
Kirukaran                                                 _____________________ 
 
Devathathan                                               ______________________ 
     
Tananjeyan                    _____________________ 
    
vii. AZHAL                                 Normal          Affected                                           
Anala pittham                            ____________________ 
 
Prasaka pittham            __________________ 
 
Ranjaka pitham                                                 ______________________ 
                                           
 Aalosaka pitham                                              ______________________ 
  
                                                                                                                                                                     
Saathga pitham                                                    ______________________ 
  
                                                                                                                                                                      
                                  
viii. IYAM                                  Normal           Affected                                          
Avalambagam                     ______________________ 
 
Kilethagam   
                                                                                 _____________________  
Pothagam                         ______________________ 
 
Tharpagam                            _______________________     
      
Santhigam                                                                ______________________ 
 
ix.UDAL THATHUKKAL    Normal            Affected                            
Saaram                            _______________________ 
 
Chenneer                                                                 _______________________ 
             
  Oon                                    _____________________ 
 
Kozhuppu                                _______________________ 
 
Enbu                                    _______________________ 
     
Moolai                                      ______________________ 
 
 
Sukkilam /  
  Suronitham             _______________________    
  
x.ENVAGAITHERVUKAL      Normal        Affected                                                                                                                                                               
                           
Naa                                                     _____________________ 
 
Niram                                                   _____________________ 
 
  Mozhi                                            _____________________ 
 
Vizhi                                         ____________ 
 
      Sparisam:       1.Mithaveppam         2.Miguveppam         
                    
        3. Thatpam 
 Malam            Normal        Affected     
Niram                       
_ 
Nurai 
.     
Karumai  
                                                  
Kalappu  
                     
Thanmai 
                        
Moothiram        
Neerkuri 
   
 Niram                  ______________________ 
 
Eadai                                       _____________________ 
                                
Manam               ______________________  
 
Nurai                  ______________________ 
 
Enjal                    ______________________ 
 
Neikuri:    1.Vatham                  2. Pittham               3. Khabam      
        
Naadi:    1.Vatham        2.Pittham                  3.khabam        
    
      4. Vathapittham             5. Vathakhabam            6. Pitthavatham   
  




TC (cells /cumm): 
 
DC (%):         P P   E              L       B             E     B 
 
       M                       
 
Hb (gm %):                  . 
 
        ESR (mm/hr):       1/2hr                          1hr 
 
 Blood Sugar (F) (mg %): 
 
Post Prandial (mg %): 
 
  
Random (mg %) 
 
Blood Urea (mg %):     
 
Serum Creatinine (mg %):              .  . 
  
Serum Cholesterol (mg %): 
      URINE 
Albumin:      0. Nil  1. Trace  2. +  3. +  4. + + +    
                                                                                                                                                
Sugar (F):          0. Nil  1. Trace  2. +   3. + +         
 
      4. + + + 
 
Sugar (PP):        0. Nil 1. Trace  2. +   3. + +         
 
      4. + + + 
         
Deposit                                    Yes                No 
 
Pus cells                       
 
Epithelial cells             
 
RBC                               
 
Crystals                             
 
MOTION                          Present       Absent 
 Ova  
Cyst 
                                                                                                                                                                                                                                                       
Occult blood  
 
Pus cells   
ADMITTED TO TRIAL:     1.Yes              2. No   
If yes   
 
 S. No:    
                 
     I.P / O.P       1. I.P        2. O.P  
 Drug issued for OP patient (g): 
 
Station                                                                                            
                                                                                       Signature of the investigator  
Date:                                                                                        
  
 
                                Signature of the Faculty 
 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUG NELLI VATRAL 
CHOORANAM IN THE TREATMENT  OF  PEENISM(SINUSITIS) 
                                                                 -A PILOT STUDY 
FORM-II ASSESSMENT PEROFORMA 
 
1. O.P.No / I.P No:  ________ 2.  Bed No: ________ 3. S.No: ________    
 
4. Name: ________________  
 
5.Date of Admission to the trial  
 
6.Day of Assessment  
 
7.CLINICAL EXAMINATION    Yes                    No 










Tenderness in the frontal  
        region 
    
    Tenderness in the maxillary 
       region     
 
Body pain 
   
Change in sense of smell 
 
 8.ENVAGAI THERVU. 
                                              1. Normal        2. Affected                                                                                                                                                               
                           
  Naa                                               _____________________ 
 
Niram                                            _____________________ 
 
Mozhi                                        _____________________ 
 
Vizhi                                   ______________________   
 
Sparisam:      1.Mithaveppam           2.Miguveppam         
                    
           Thatpam 
   Malam         Normal        Affected     
Niram                      
 
Nurai 
.    
Karumai  
                                                  
  Kalappu  
                     
 Thanmai                        
Moothiram        
Neerkuri   
  Niram                               ______________________ 
     
 Eadai                                        _____________________ 
                                
  Manam                             ______________________  
 
  Nurai                             ______________________ 
 
Enjal                                      ______________________ 
 
  Neikuri: 1.Vatham             2. Pittham         3. Khabam      
        
 Naadi:    1.Vatham        2.Pittham                  3.khabam         
   
     4. Vathapittham             5. Vathakhabam            6. Pitthavatham   
  
     7. Pitthakhabam              8. Khabavatham            9. Khabapittham    
 
FOR OP PATIENTS   
  DRUGS ISSUE           1. No. of Packs                      
                
  DRUGS RETURNED  1. No. of Packs      
 
                 
 
Station                                                                                            
                                                                                         Signature of the investigator  
 Date:                                                                                        
  
                                Signature of the Faculty 
LABORATORY  INVESTIGATIONS  
BLOOD  
 TC (cells /cumm): 
 
 DC (%):         P                           L                    E     B 
 
       M                       
 
  
Hb (gms %):                  . 
 
 ESR (mm/hr):                  1/2hr                                1hr 
 
Blood Sugar (F) (mg %): 
 




Albumin:    0. Nil             1. Trace  2. +  3. + + 
  
 4. + + +    
Fasting :          0. Nil            1. Trace            2. +                3. + +         
 
                         4. + + + 
 
 Post Prandial:  0. Nil               1. Trace                  2. +  3.               3.  + +         
 
    4. + + + 
   
 Deposit               1. Yes                    2. No 
  
MOTION                                 Present       Absent   
   
30. Ova  
31. Cyst                                                                                                                                                                                                                                                
32. Occult blood 
RESULT       Cured                            Improved       No change 
            
 Station                                                                                            
                                                                                  Signature of the investigator 
Date:                                                                                        
  




A PILOT OPEN CLINICAL TRIAL OF SIDDHA DRUG NELLI VATRAL 
CHOORANAM   FOR THE TREATMENT OF PEENISM (SINUSITIS) 
 
   CONSENT FORM 
 
CERTIFICATE BY INVESTIGATOR 
 
 I certify that I have disclosed all details about the study in the terms readily understood               




Signature of the patient / volunteers  _______ 
 
Station: ___________ 
                                                            Name: ____________________ 
 
                                              
                                                 CONSENT BY PATIENT 
 
  I have been informed to my satisfaction, by the attending physician, the purpose of the 
clinical trial, and the nature of the drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my body functions. 
  I, exercising my free power of choice, hereby give my consent to be included as a 
subject in the clinical trial of  Nelli Vatral Chooranam on  Peenism 
 
  Date: _____________                                            




 Station: _____________                        Name: _____________________ 
 
                                                                Signature of witness: _____________ 
 
 
 Date: ____________                             Name: ___________________   
   
 Station:  ___________                          Relationship: _________________ 
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A  OPEN CLINICAL TRIAL OF DEEPALINGA CHENDOORAM  IN THE  
TREATMENT OF KARAPPAN (ECZEMA)               
                                                                                    -A PILOT STUDY 
FORM I-SELECTION PERFORMA 
 
1. OP/IP No:_________________              2.BED No:_______3.S.No:_______________ 
 
4. NAME:__________________________5.AGE:_______Yrs 6.GENER:____________ 
 
7. DATE OF ADMISSION TO THE TRIAL 
 
8. OCCUPATION: ________________________ 
 




                                       ______________________________________ 
 
10. COMPLAINS & DURATION: 





11. HISTORY OF PRESENT ILLNESS: 






12. PAST HISTORY: 
                …………………………………………………………………………………… 
……………………………………………………………………………………………… 
 
13. FAMILY HISTORY: 
               ……………………………………………………………………………………. 
……………………………………………………………………………………………… 
 
14. MENSTRUAL HISTORY: Regular Irregular                  Not applicable  
 
 
                                                             2 
15. SOCIAL HISTORY: 






16.HABITS                                 Yes                No 




iii. Betel nut chewer 
 
iv. Non-Vegetarian           
 
17.GENERAL EXAMINATION 
i. Built : Normosthenic                              Hypersthenic         Hyposthenic      
 
ii. Nutrition : Normal                 Underweight                Overweight               
 
iii. Body weight (kg)  :       
 
iv. Body temperature (F)        :                            .           
 
v. Blood Pressure (mmHg) : /   
 
vi. Pulse Rate/min  : 
 
vii. Heart Rate/min  : 
 
viii. Respiratory Rate/min : 
 
 
                    Yes                No 
ix. Pallor  :  
 
x. Jaundice  : 
 
xi. Clubbing  : 
 
xii. Cyanosis  : 
 
xiii. Pedal Oedema  : 
 
xiv. Lymphadenopathy  : 
 
xv. Jugular venous pulsation    : 
 18.CLINICAL EXAMINATION OF SKIN: 
 
i. ANATOMICAL LOCATION…………………………………. 
 
ii. COLOUR -Normal            Hyperpigmented                 Hypopigmented 
                                                                  
iii. SIZE OF THE LESION (Length cm): ……………………………    
 
iv. SHAPE:            Irregular             Round                    Dispersed 
 
v. PRURITUS:       Present                     Absent 
 
vi. SWELLING:      Present                    Absent 
 
vii. ERYTHEMA:    Present                     Absent 
 
viii. DEPIGMENTATION OF SKIN 
 




                              Normal                     Paraesthesia                     Numbness 
 
  Painful                     Burning                            Pricking  
 
x. SCALING:        Present      Absent 
 
xi. CRUSTING:       Present      Absent 
 
xii. OOZING:            Present      Absent 
 
xiii. MACULES:        Present      Absent 
 
xiv. PAPULES:          Present      Absent 
 
xv. VESICLES:         Present      Absent 
 
xvi. PUSTULES:        Present      Absent 
 
xvii. PALPATION: 
                                Normal                          Smooth                              Rough 
                        
                               Warm                             Cold 
 
19. EXAMINATION OF VITAL ORGANS: 
                                          Normal             Abnormal  
i. CNS                                                                ...………………………………… 
 ii. CVS                                                               ………………………………….. 
 
iii. RS                                                                       …….............................................. 
 
iv. ABDOMEN                                                       ………………………………….. 
 





1.Kurinji                2.Mullai              3.Marutham              4.Neithal              5.Palai    
 
ii. KAALA  IYALBU: 
  
1.Kaarkaalam                    2.Koothirkaalam                   3.Munpanikaalam            
 
4.Pinpanikaalam              5.Illavenilkaalam                 6.Muthuvenilkaalam 
 
iii. UDAL  IYALBU: 
 
1.Vadam          2.Pitham           3.Kabam           4.Vathapitham            5.Vathakabam 
 




            1. Sathuvam                       2.Rasatham                          3.Thamasam 
v. AYMPORIGAL: 
                                     Normal              Affected 
 
Mei                                                   ................................................... 
 
Vaai                                                      ………………………………… 
 
Kan                                                       ………………………………… 
 
Mookku                                                ………………………………… 
          
Sevi                                                      …………………………………. 
 
vi.KANMENTHIRIUM / KANMAVEDAYAM 
                                   Normal                 Affected 
 
Kai                                                        …………………………………….. 
 
Kaal    …………………………………….. 
 
Vaai   …………………………………….. 
 Earuvai   …………………………………….. 
 
 Karuvai     …………………………………….. 
                                                                                                                          
 
vii. UYIR THATHUKKAL 
 
     (a).VATHAM 
                                        Normal             Affected  
Pranan   ……………………………………………….   
   
Abanan   ……………………………………………….. 
  
Viyanan    ……………………………………………….. 
 
Uthanan    ……………………………………………….. 
 
Samanan    ………………………………………………... 
 
Nagan    ……………………………………………….. 
 
Koorman   ………………………………………………..  
 
Kirukaran    ……………………………………………… 
 
 Devathathan    ………………………………………………. 
 
Dhananjeyan     ……………………………………………….. 
     
     (b). PITTHAM:   
                                         Normal           Affected     
Anarpittham     …………………………………………….. 
         
 Ranjagam   ……………………………………………… 
 
.Sathagam   ………………………………………………. 
 
Alosagam   ……………………………………………… 
 
 Prasagam                      ……………………………………………….   
 
     (c). KABAM 
                                         Normal           Affected  
 
Avalambagam   ………………………………………………..  
 
Kilethagam   ………………………………………………. 
 
 Pothagam    ……………………………………………… 
  Tharpagam    ………………………………………………. 
 
Santhegam                                            ……………………………………………… 
 
 
                                                                      
viii. UDAL THATHUKKAL: 
                                        Normal         Affected    
Saaram   ………………………………………………  
 
Senneer           ………………………………………………. 
 
Oon           ………………………………………………. 
 
Kozhuppu                         ………………………………………………. 
 
 Enbu              ……………………………………………… 
 
Moolai                                              ……………………………………………… 
 
Sukkilam/                               
Suronitham                                       ……………………………………………….. 
 
(ix). ENVAGAI THERVUGAL 
 
 Naadi    ………………………………………………………………. 
                                        Normal           Affected     
.Naa  
 
  Niram  
 




 Sparisam  
 
             Malam                 Normal  Affected  
 
 Niram 
                                          Yes                  No  
      Nurai 
 
       Kirumi  
 
       Kalappu 
 
       Erugal 
 





                                     Normal          Affected  
Niram        
 
Manam       
 







      Neikuri      Vatha neer(1)              Pitha neer(2)              Kaba neer(3) 
                               
LAB INVESTIGATION 
BLOOD 
TC (Cells/Cu mm) 
 
 DC (%)-         N-                        L-                M-                             E -                   B- 
 
 ESR (mm)-        1/2 hr-                               1 hr- 
 
 Hb (gm%)-                
   
Blood Sugar (gm %) 
Fasting                                 Post Prandial 





 Blood Cholesterol(mg%) 
 
            S. creatinine(mg%)                         .   
  
URINE   
                                             Present        Absent  
Albumin                 -                                         ……………………………............. 
  
Sugar                      -                                         …………………………………… 
 
 
Deposit                               Present          Absent  
 
Pus cells                 -                                     …………………………………… 
 
Epithelial cells       -                                           ……………………………… 
 
Red cells            -                                               …………………………………… 
 
Casts/Crystal     -                                                …………………………………… 
 
MOTION                           Present           Absent   
                                        
Ova    - 
  
Cyst                  -  
 
 
Occult blood    - 
 
Pus cells  - 
 




2.Age between 15 to 70 years. 
 
3.Willing to be admitted as In patient in our ward for 48 days  
   or willing to attend OPD once in 7 days for 48 days. 
 
4.Willing to give blood specimen and photograph before and  
   after treatment. 
 






3.Connective tissues disorders  
 
4.Cardiac disease  
                                                                                                                 NA*          
5.Pregnancy 
6. Lactation 
                                                                                                         (*NA-Not applicable) 
7.Malignancy      
 
I.Admitted to trail:                      Yes               No    
 




Drug issued for O.P.Patients: 
 
 1.No.of  packs:__________ 
 
 
Date:…………………                                                                    
                                                                                                       Signature of Investigator 
 
Station:……………….                                                           
 
 
                                                                                                          Signature of Faculty 
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 A  PILOT OPEN CLINICAL TRIAL OF DEEPALINGA CHENDOORAM 
FOR THE TREATMENT OF KARAPPAN  (ECZEMA) 
 
FORM II-ASSESSMENT PERFORMA 
 




5. DATE OF ADMISSION: 
 
6. DATE OF ASSESSMENT: 
 
7. DAY OF ASSESSMENT: 
 
CLINICAL ASSESSMENT CHART: 
 
8. ANATOMICAL LOCATION…………………………………. 
 
9. COLOUR           Normal              Hyperpigmented                 Hypopigmented 
 
10. SIZE OF THE LESION (Length cm):……………………………     
 
11. SHAPE:            Irregular          Round                    Dispersed 
 
12. PRURITUS:       Present                     Absent 
 
13. SWELLING:      Present                     Absent 
 
14. ERYTHEMA:     Present                    Absent 
 
15. DEPIGMENTATIOPN OF HAIR 
 




                              Normal                 Paraesthesia                     Numbness 
 
  Painful                 Burning                            Pricking  
 
17. SCALING:        Present      Absent 
 
18. CRUSTING:       Present      Absent 
                                                                      2 
 19. OOZING:            Present      Absent 
 
20. MACULES:        Present      Absent 
 
21. PAPULES:          Present      Absent 
 
22. VESICLES:         Present      Absent 
 
23. PUSTULES:        Present      Absent 
 
24. PALPATION: 
                                Normal                          Smooth                              Rough 
                        
                                Warm                             Cold 
 
25.PIGMENTATION   :          Present            Absent 
 
      ………………………………………………………………………………………….. 
 
26.Naadi……………………………………………………………………………………. 
                                             
LAB INVESTIGATION :( Only on Day 1, 21and Day 48) 
BLOOD: 
27. TC (Cells/Cu mm) 
 
DC (%)      28.N-                       29.L-                  30.M-              31.E -                32.B- 
 
ESR (mm) 33.1/2 hr-                             34.1 hr- 
 
35. Hb (gm %)-               S 
   
Blood Sugar(gm%) 
36.Fasting                               37.Post Prandial 








URINE:                             Present (1)         Absent (2)                                          
41.Albumin                                                        ……………………………............. 
  
42.Sugar                                                             …………………………………… 
 
                                                                3 
    Deposit                          Present (1)         Absent (2)                                          
 43.Pus cells            -                                     …………………………………… 
 
 44.Epithelial cells  -                                 …………………………………… 
 
 45.Red cells            -                                     …………………………………… 
 
 46.Casts/Crystal     -                                    …………………………………… 
 
MOTION:                        Present (1)         Absent (2)                                          
47. Ova  - 
  
48. Cyst  - 
 
49. Occult blood- 
 




52. NEIKURI:           Vatha neer(1)              Pitha neer(2)              Kaba neer(3) 
 
 
53. RESULT:            Cured                         Improved                       No change 
 
FOR O.P.PATIENTS: 
54. Drugs returned: 
    1. No of packs:……………..   
 
55. Drugs issued: 
   1. No. of pack……………… 
 
 
 56. YENVAGAI THERVU. 
 
           NAADI      
                                                                                                                                                                                                                                                                                                                         
           SPARISM. 
  
           NAA. 
 
           NIRAM 
              
            MOZHI. 
 
            VIZHI 
 
            MALAM 
         






57. Station:                                                                                   Signature of Doctor 
  
 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUG DEEPALINGA 
CHENDOORAM FOR THE TREATMENT OF KARAPPAN ( ECZEMA ) 
     -A PILOT STUDY 
   CONSENT FORM 
 
CERTIFICATE BY INVESTIGATOR 
 
 I certify that I have disclosed all details about the study in the terms readily understood               
by the patient. 
 
Date: _____________ 
                                                                                                                                       




                                                            Name: ____________________ 
 
                                              
                                                 CONSENT BY PATIENT 
 
  I have been informed to my satisfaction, by the attending physician, the purpose of the 
clinical trial the nature of the drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my body functions. 
 
  I, exercising my free power of choice, hereby give my consent to be included as a 
subject in the clinical trial of  Deepalinga chendooram  on  Karappan  
 
 
  Date: _____________                                            
                                                                                                                                             
Signature of the patient / volunteers  _________________  
  
 Station: _____________                        Name: _____________________ 
 
                                                                Signature of witness: _____________ 
 
 
 Date: ____________                             Name: ___________________   
   
 Station:  ___________                          Relationship: _________________ 
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